{"data":[{"id":641,"nct":"NCT05009732","title":"A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-09-29","primary_completion_date":"2022-05-31","completion_date":"2022-10-31","first_posted_date":"2021-08-16"},{"id":640,"nct":"NCT05157997","title":"Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-12-31","primary_completion_date":"2023-12-31","completion_date":"2024-12-31","first_posted_date":"2021-12-14"},{"id":639,"nct":"NCT04712279","title":"The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-01-24","primary_completion_date":"2021-03-20","completion_date":"2021-04-19","first_posted_date":"2021-01-14"},{"id":638,"nct":"NCT04668469","title":"Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic","status":"Completed","result":"No Results Available","phases":"Not Applicable","start_date":"2020-06-07","primary_completion_date":"2020-09-14","completion_date":"2020-10-29","first_posted_date":"2020-12-15"},{"id":637,"nct":"NCT04768179","title":"Safety & Efficacy of Low Dose Aspirin \/ Ivermectin Combination Therapy for Treatment of Covid-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-02-18","primary_completion_date":"2021-06-29","completion_date":"2021-09-29","first_posted_date":"2021-02-23"},{"id":636,"nct":"NCT04930861","title":"Study of Codivir in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 1","start_date":"2021-03-28","primary_completion_date":"2021-05-26","completion_date":"2021-08-08","first_posted_date":"2021-06-17"},{"id":635,"nct":"NCT04359680","title":"Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-12","primary_completion_date":"2021-03-28","completion_date":"2021-03-28","first_posted_date":"2020-04-23"},{"id":634,"nct":"NCT04854486","title":"Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-12-15","primary_completion_date":"2022-03-29","completion_date":"2022-11-15","first_posted_date":"2021-04-21"},{"id":633,"nct":"NCT04379479","title":"Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-30","primary_completion_date":"2020-07-31","completion_date":"2020-11-30","first_posted_date":"2020-05-06"},{"id":632,"nct":"NCT04981379","title":"Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-15","primary_completion_date":"2021-01-30","completion_date":"2021-02-15","first_posted_date":"2021-07-28"},{"id":631,"nct":"NCT04355793","title":"Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection","status":"No longer available","result":"No Results Available","phases":null,"start_date":null,"primary_completion_date":null,"completion_date":null,"first_posted_date":"2020-04-20"},{"id":630,"nct":"NCT04540406","title":"NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-09-30","primary_completion_date":"2021-11-30","completion_date":"2021-12-31","first_posted_date":"2020-09-06"},{"id":629,"nct":"NCT04366960","title":"Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-13","primary_completion_date":"2021-05-24","completion_date":"2021-05-24","first_posted_date":"2020-04-28"},{"id":628,"nct":"NCT04414098","title":"Ruxolitinib in the Treatment of Covid-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-31","primary_completion_date":"2020-08-14","completion_date":"2020-09-14","first_posted_date":"2020-06-03"},{"id":627,"nct":"NCT04623021","title":"A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-24","primary_completion_date":"2020-12-11","completion_date":"2020-12-11","first_posted_date":"2020-11-09"},{"id":626,"nct":"NCT04354870","title":"COVID-19 PrEP HCW HCQ Study","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-04-02","primary_completion_date":"2020-09-14","completion_date":"2020-09-30","first_posted_date":"2020-04-20"},{"id":625,"nct":"NCT04780321","title":"JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-10-29","primary_completion_date":"2021-09-30","completion_date":"2021-10-29","first_posted_date":"2021-03-02"},{"id":624,"nct":"NCT04461340","title":"Efficacy and Safety of Sirolimus in COVID-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-14","primary_completion_date":"2020-10-29","completion_date":"2020-11-29","first_posted_date":"2020-07-07"},{"id":623,"nct":"NCT04348448","title":"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":null,"start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2020-08-31","first_posted_date":"2020-04-15"},{"id":622,"nct":"NCT04527562","title":"Colchicine in Moderate Symptomatic COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Not Applicable","start_date":"2020-07-13","primary_completion_date":"2020-11-14","completion_date":"2020-12-09","first_posted_date":"2020-08-25"},{"id":621,"nct":"NCT04849637","title":"Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-21","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2021-04-18"},{"id":620,"nct":"NCT04425772","title":"A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19\uff09","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-06-11","primary_completion_date":"2020-08-11","completion_date":"2020-08-11","first_posted_date":"2020-06-10"},{"id":619,"nct":"NCT04531748","title":"Selective Estrogen Modulation and Melatonin in Early COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2021-11-30","primary_completion_date":"2022-08-31","completion_date":"2022-08-31","first_posted_date":"2020-08-27"},{"id":618,"nct":"NCT04359511","title":"Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia","status":"Withdrawn","result":"No Results Available","phases":"Phase 3","start_date":"2020-07-02","primary_completion_date":"2020-07-02","completion_date":"2020-07-02","first_posted_date":"2020-04-23"},{"id":617,"nct":"NCT04449380","title":"Clinical Study for the Treatment With Interferon-\u00df-1a (IFN\u00df-1a) of COVID-19 Patients","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-01","primary_completion_date":"2021-03-29","completion_date":"2021-03-29","first_posted_date":"2020-06-25"},{"id":616,"nct":"NCT04425460","title":"A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-31","primary_completion_date":"2020-07-31","completion_date":"2020-08-31","first_posted_date":"2020-06-10"},{"id":615,"nct":"NCT04663737","title":"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-12-02","primary_completion_date":"2021-08-15","completion_date":"2021-09-29","first_posted_date":"2020-12-10"},{"id":614,"nct":"NCT04500132","title":"To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-27","primary_completion_date":"2021-07-31","completion_date":"2022-04-30","first_posted_date":"2020-08-04"},{"id":613,"nct":"NCT04676971","title":"Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-12-10","primary_completion_date":"2021-08-28","completion_date":"2021-10-27","first_posted_date":"2020-12-20"},{"id":612,"nct":"NCT04539626","title":"Estrogen Therapy in Non-severe COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-09-30","primary_completion_date":"2021-06-30","completion_date":"2022-11-30","first_posted_date":"2020-09-06"},{"id":611,"nct":"NCT04803227","title":"Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-03-10","primary_completion_date":"2021-03-31","completion_date":"2021-05-31","first_posted_date":"2021-03-16"},{"id":610,"nct":"NCT04541979","title":"Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-03","primary_completion_date":"2021-04-30","completion_date":"2021-05-31","first_posted_date":"2020-09-08"},{"id":609,"nct":"NCT04358809","title":"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-29","primary_completion_date":"2021-02-27","completion_date":"2021-04-29","first_posted_date":"2020-04-23"},{"id":608,"nct":"NCT04577534","title":"COVID-19: Salvage TOcilizumab as a Rescue Measure","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-08-13","primary_completion_date":"2021-06-15","completion_date":"2021-06-15","first_posted_date":"2020-10-07"},{"id":607,"nct":"NCT04451174","title":"Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-22","primary_completion_date":"2021-01-29","completion_date":"2021-01-29","first_posted_date":"2020-06-29"},{"id":606,"nct":"NCT04584697","title":"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG\u2122) in Outpatients With COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-11-30","primary_completion_date":"2021-03-31","completion_date":"2021-03-31","first_posted_date":"2020-10-13"},{"id":605,"nct":"NCT04498325","title":"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)","status":"Withdrawn","result":"No Results Available","phases":"Phase 1","start_date":"2021-07-30","primary_completion_date":"2022-04-29","completion_date":"2022-04-29","first_posted_date":"2020-08-03"},{"id":604,"nct":"NCT04941183","title":"Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-04-13","primary_completion_date":"2021-10-31","completion_date":"2021-10-31","first_posted_date":"2021-06-27"},{"id":603,"nct":"NCT04643691","title":"Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-10","primary_completion_date":"2022-09-29","completion_date":"2022-10-29","first_posted_date":"2020-11-24"},{"id":602,"nct":"NCT04528667","title":"Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2021-01-05","primary_completion_date":"2021-08-22","completion_date":"2021-10-06","first_posted_date":"2020-08-26"},{"id":601,"nct":"NCT04567173","title":"Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-09-20","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2020-09-27"},{"id":600,"nct":"NCT05122208","title":"Famotidine in Covid-19 Intensive Care Unit","status":"Completed","result":"No Results Available","phases":null,"start_date":"2020-03-19","primary_completion_date":"2021-03-29","completion_date":"2021-08-14","first_posted_date":"2021-11-15"},{"id":599,"nct":"NCT04411680","title":"Study of Sargramostim in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-17","primary_completion_date":"2021-03-01","completion_date":"2021-05-18","first_posted_date":"2020-06-01"},{"id":598,"nct":"NCT04417257","title":"Study of LAU-7b for the Treatment of COVID-19 Disease in Adults","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-28","primary_completion_date":"2021-07-14","completion_date":"2021-07-14","first_posted_date":"2020-06-03"},{"id":597,"nct":"NCT04900428","title":"Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS\u2122) in Outpatient Adults With COVID-19 (UK)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-07-17","primary_completion_date":"2021-12-31","completion_date":"2022-02-28","first_posted_date":"2021-05-24"},{"id":596,"nct":"NCT05008393","title":"Efficacy of PJS-539 for Adult Patients With COVID-19.","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-09-24","primary_completion_date":"2021-11-29","completion_date":"2021-12-29","first_posted_date":"2021-08-16"},{"id":595,"nct":"NCT04734860","title":"Study to Evaluate a Single Dose of STI-2020 (COVI-AMG\u2122) in Adults With Mild COVID-19 Symptoms","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-08-31","completion_date":"2021-10-31","first_posted_date":"2021-02-01"},{"id":594,"nct":"NCT04771351","title":"Study to Evaluate a Single Dose of STI-2020 (COVI-AMG\u2122) in Hospitalized Adults With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-07-31","completion_date":"2021-09-30","first_posted_date":"2021-02-24"},{"id":593,"nct":"NCT04906694","title":"Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS\u2122) in Outpatient Adults With COVID-19 (US)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-09-30","primary_completion_date":"2022-01-31","completion_date":"2022-05-31","first_posted_date":"2021-05-27"},{"id":592,"nct":"NCT04750317","title":"Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-10","primary_completion_date":"2020-07-31","completion_date":"2020-08-31","first_posted_date":"2021-02-10"},{"id":591,"nct":"NCT04990466","title":"Phase 2b\/3 Trial of VSV-\u0394G SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-09-29","primary_completion_date":"2021-12-30","completion_date":"2022-02-27","first_posted_date":"2021-08-03"},{"id":590,"nct":"NCT04738175","title":"Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG\u2122) to Treat COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-10-31","completion_date":"2021-10-31","first_posted_date":"2021-02-03"},{"id":589,"nct":"NCT04646031","title":"Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19","status":"Available","result":"No Results Available","phases":null,"start_date":null,"primary_completion_date":null,"completion_date":null,"first_posted_date":"2020-11-26"},{"id":588,"nct":"NCT04742725","title":"A Study to Evaluate the Efficacy and Safety of Prothione\u2122 Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-05-24","primary_completion_date":"2021-07-29","completion_date":"2021-09-29","first_posted_date":"2021-02-07"},{"id":587,"nct":"NCT04382755","title":"Zilucoplan\u00ae in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-21","primary_completion_date":"2020-12-28","completion_date":"2021-04-08","first_posted_date":"2020-05-10"},{"id":586,"nct":"NCT04407130","title":"Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-15","primary_completion_date":"2020-10-29","completion_date":"2020-11-19","first_posted_date":"2020-05-28"},{"id":585,"nct":"NCT04455815","title":"A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive.","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-24","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2020-07-01"},{"id":584,"nct":"NCT04498273","title":"COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-09-06","primary_completion_date":"2021-08-04","completion_date":"2021-08-04","first_posted_date":"2020-08-03"},{"id":583,"nct":"NCT04380519","title":"Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)","status":"Completed","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-22","primary_completion_date":"2020-07-09","completion_date":"2020-07-23","first_posted_date":"2020-05-07"},{"id":582,"nct":"NCT04905836","title":"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-11-15","primary_completion_date":"2021-11-30","completion_date":"2022-02-28","first_posted_date":"2021-05-27"},{"id":581,"nct":"NCT04452474","title":"Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).","status":"Withdrawn","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-06-29","primary_completion_date":"2020-11-15","completion_date":"2021-01-28","first_posted_date":"2020-06-29"},{"id":580,"nct":"NCT04357535","title":"Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives","status":"Completed","result":"No Results Available","phases":null,"start_date":"2020-05-09","primary_completion_date":"2020-06-30","completion_date":"2020-07-31","first_posted_date":"2020-04-21"},{"id":579,"nct":"NCT04485429","title":"Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia","status":"Withdrawn","result":"No Results Available","phases":"Phase 3","start_date":"2020-07-19","primary_completion_date":"2022-12-30","completion_date":"2022-12-30","first_posted_date":"2020-07-23"},{"id":578,"nct":"NCT04371822","title":"Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-07-31","primary_completion_date":"2020-09-30","completion_date":"2020-10-31","first_posted_date":"2020-04-30"},{"id":577,"nct":"NCT04541485","title":"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)","status":"Terminated","result":"No Results Available","phases":"Phase 1","start_date":"2020-12-03","primary_completion_date":"2021-03-02","completion_date":"2021-03-22","first_posted_date":"2020-09-08"},{"id":576,"nct":"NCT04903327","title":"Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-11-15","primary_completion_date":"2021-11-30","completion_date":"2022-01-31","first_posted_date":"2021-05-25"},{"id":575,"nct":"NCT04810689","title":"Pilot Trial of XFBD, a TCM, in Persons With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-02-28","primary_completion_date":"2022-02-28","completion_date":"2022-08-31","first_posted_date":"2021-03-22"},{"id":574,"nct":"NCT04389411","title":"The COvid-19 Symptom MOntelukast Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-09-30","primary_completion_date":"2021-08-31","completion_date":"2021-11-30","first_posted_date":"2020-05-14"},{"id":573,"nct":"NCT04713176","title":"Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-02-01","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2021-01-18"},{"id":572,"nct":"NCT04978051","title":"Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-04-11","primary_completion_date":"2021-11-29","completion_date":"2021-12-29","first_posted_date":"2021-07-26"},{"id":571,"nct":"NCT04427098","title":"Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-21","primary_completion_date":"2020-10-29","completion_date":"2020-10-29","first_posted_date":"2020-06-10"},{"id":570,"nct":"NCT05060666","title":"Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-10-31","primary_completion_date":"2022-02-28","completion_date":"2022-02-28","first_posted_date":"2021-09-28"},{"id":569,"nct":"NCT04859517","title":"Evaluation of ADG20 for the Prevention of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-04-22","primary_completion_date":"2022-06-30","completion_date":"2023-02-28","first_posted_date":"2021-04-25"},{"id":568,"nct":"NCT04762186","title":"Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-12-07","primary_completion_date":"2023-01-31","completion_date":"2023-01-31","first_posted_date":"2021-02-20"},{"id":567,"nct":"NCT04718480","title":"Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-26","primary_completion_date":"2022-07-31","completion_date":"2022-11-30","first_posted_date":"2021-01-21"},{"id":566,"nct":"NCT04425252","title":"Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-07-31","primary_completion_date":"2020-12-28","completion_date":"2020-12-28","first_posted_date":"2020-06-10"},{"id":565,"nct":"NCT04709172","title":"Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2021-01-04","primary_completion_date":"2021-08-14","completion_date":"2021-08-14","first_posted_date":"2021-01-13"},{"id":564,"nct":"NCT04979221","title":"Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-07-25","primary_completion_date":"2022-01-25","completion_date":"2022-02-27","first_posted_date":"2021-07-27"},{"id":563,"nct":"NCT04871633","title":"Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore","status":"Completed","result":"No Results Available","phases":"Not Applicable","start_date":"2020-07-31","primary_completion_date":"2020-11-14","completion_date":"2020-12-29","first_posted_date":"2021-05-03"},{"id":562,"nct":"NCT05067933","title":"A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-09-30","primary_completion_date":"2022-02-28","completion_date":"2023-05-31","first_posted_date":"2021-10-04"},{"id":561,"nct":"NCT05118763","title":"Intranasal INNA-051 for Prevention of COVID-19 in Adults","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2022-02-28","primary_completion_date":"2022-12-30","completion_date":"2022-12-30","first_posted_date":"2021-11-11"},{"id":560,"nct":"NCT04381962","title":"A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-02","primary_completion_date":"2021-01-28","completion_date":"2021-04-19","first_posted_date":"2020-05-10"},{"id":559,"nct":"NCT04593940","title":"Immune Modulators for Treating COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-10-14","primary_completion_date":"2022-07-31","completion_date":"2022-08-31","first_posted_date":"2020-10-19"},{"id":558,"nct":"NCT04353596","title":"Stopping ACE-inhibitors in COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-19","primary_completion_date":"2021-02-15","completion_date":"2021-02-23","first_posted_date":"2020-04-19"},{"id":557,"nct":"NCT04346615","title":"Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-24","primary_completion_date":"2022-04-29","completion_date":"2022-04-29","first_posted_date":"2020-04-14"},{"id":556,"nct":"NCT04371965","title":"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-31","primary_completion_date":"2020-10-22","completion_date":"2020-10-22","first_posted_date":"2020-04-30"},{"id":555,"nct":"NCT04959786","title":"MANS-NRIZ Trial for COVID-19 Treatment : Extension Study","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-03-31","primary_completion_date":"2022-10-31","completion_date":"2022-11-30","first_posted_date":"2021-07-12"},{"id":554,"nct":"NCT04426084","title":"Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study","status":"Active, not recruiting","result":"No Results Available","phases":null,"start_date":"2020-02-29","primary_completion_date":"2020-05-10","completion_date":"2022-12-30","first_posted_date":"2020-06-10"},{"id":553,"nct":"NCT04926428","title":"In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection","status":"Completed","result":"No Results Available","phases":"Not Applicable","start_date":"2020-12-24","primary_completion_date":"2021-03-29","completion_date":"2021-03-29","first_posted_date":"2021-06-14"},{"id":552,"nct":"NCT05157139","title":"Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-10-31","primary_completion_date":"2022-02-28","completion_date":"2022-03-31","first_posted_date":"2021-12-13"},{"id":551,"nct":"NCT04365257","title":"Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-12","primary_completion_date":"2022-03-29","completion_date":"2022-03-29","first_posted_date":"2020-04-27"},{"id":550,"nct":"NCT04794998","title":"A Simple Approach to Treat COVID-19 Patients at Home.","status":"Completed","result":"No Results Available","phases":null,"start_date":"2021-02-07","primary_completion_date":"2021-07-30","completion_date":"2021-07-30","first_posted_date":"2021-03-11"},{"id":549,"nct":"NCT05122182","title":"Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-12-07","primary_completion_date":"2022-07-13","completion_date":"2022-12-28","first_posted_date":"2021-11-15"},{"id":548,"nct":"NCT05121766","title":"Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-12-14","primary_completion_date":"2022-12-31","completion_date":"2023-12-31","first_posted_date":"2021-11-15"},{"id":547,"nct":"NCT05037253","title":"COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2020-10-29","primary_completion_date":"2021-05-29","completion_date":"2021-05-29","first_posted_date":"2021-09-07"},{"id":546,"nct":"NCT04363866","title":"Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-31","primary_completion_date":"2021-02-28","completion_date":"2021-08-31","first_posted_date":"2020-04-26"},{"id":545,"nct":"NCT04931238","title":"Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-01-19","primary_completion_date":"2021-12-30","completion_date":"2022-12-30","first_posted_date":"2021-06-17"},{"id":544,"nct":"NCT04901689","title":"Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-10-22","primary_completion_date":"2022-01-31","completion_date":"2022-01-31","first_posted_date":"2021-05-24"},{"id":543,"nct":"NCT04448119","title":"Control of COVID-19 Outbreaks in Long Term Care","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-15","primary_completion_date":"2021-10-31","completion_date":"2021-10-31","first_posted_date":"2020-06-24"},{"id":542,"nct":"NCT05139901","title":"Usefulness of DORNASE in COVID-19 on HFNO","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2021-11-30","primary_completion_date":"2022-02-28","completion_date":"2022-05-31","first_posted_date":"2021-11-30"},{"id":541,"nct":"NCT04431453","title":"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734\u2122) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-20","primary_completion_date":"2022-01-31","completion_date":"2022-01-31","first_posted_date":"2020-06-15"},{"id":540,"nct":"NCT04473170","title":"Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-04-03","primary_completion_date":"2020-05-19","completion_date":"2020-07-13","first_posted_date":"2020-07-15"},{"id":539,"nct":"NCT04460183","title":"A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-28","primary_completion_date":"2021-01-26","completion_date":"2021-04-22","first_posted_date":"2020-07-06"},{"id":538,"nct":"NCT04360551","title":"Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-30","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2020-04-23"},{"id":537,"nct":"NCT04353518","title":"Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-29","primary_completion_date":"2021-03-29","completion_date":"2021-05-29","first_posted_date":"2020-04-19"},{"id":536,"nct":"NCT04449588","title":"Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI\/ARDS","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-22","primary_completion_date":"2021-11-29","completion_date":"2022-08-06","first_posted_date":"2020-06-28"},{"id":535,"nct":"NCT05033145","title":"Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-09-30","primary_completion_date":"2022-04-30","completion_date":"2022-06-30","first_posted_date":"2021-09-01"},{"id":534,"nct":"NCT04348409","title":"Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-05-24","primary_completion_date":"2020-07-30","completion_date":"2020-07-30","first_posted_date":"2020-04-15"},{"id":533,"nct":"NCT04377711","title":"A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-07","primary_completion_date":"2021-01-04","completion_date":"2021-01-04","first_posted_date":"2020-05-05"},{"id":532,"nct":"NCT04547127","title":"A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-28","primary_completion_date":"2021-02-03","completion_date":"2021-02-03","first_posted_date":"2020-09-13"},{"id":531,"nct":"NCT04370782","title":"Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-27","primary_completion_date":"2020-09-29","completion_date":"2020-09-29","first_posted_date":"2020-04-30"},{"id":530,"nct":"NCT04707534","title":"Dexamethasone for COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2021-01-20","primary_completion_date":"2021-08-20","completion_date":"2021-09-20","first_posted_date":"2021-01-12"},{"id":529,"nct":"NCT04385264","title":"#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19","status":"Suspended","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-12-31","primary_completion_date":"2022-07-31","completion_date":"2022-11-30","first_posted_date":"2020-05-11"},{"id":528,"nct":"NCT04745351","title":"Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-03-30","primary_completion_date":"2022-07-31","completion_date":"2022-08-31","first_posted_date":"2021-02-08"},{"id":527,"nct":"NCT04539262","title":"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation","status":"Completed","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-09-13","primary_completion_date":"2021-02-25","completion_date":"2021-03-21","first_posted_date":"2020-09-03"},{"id":526,"nct":"NCT04466280","title":"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-07-14","primary_completion_date":"2020-11-14","completion_date":"2020-12-14","first_posted_date":"2020-07-09"},{"id":525,"nct":"NCT04501952","title":"Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734\u2122) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting","status":"Terminated","result":"Has Results","phases":"Phase 3","start_date":"2020-09-17","primary_completion_date":"2021-05-05","completion_date":"2021-05-05","first_posted_date":"2020-08-05"},{"id":524,"nct":"NCT04371926","title":"Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk","status":"Withdrawn","result":"No Results Available","phases":"Not Applicable","start_date":"2020-05-31","primary_completion_date":"2021-05-31","completion_date":"2021-06-30","first_posted_date":"2020-04-30"},{"id":523,"nct":"NCT04427501","title":"A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-06-16","primary_completion_date":"2021-02-15","completion_date":"2021-12-16","first_posted_date":"2020-06-10"},{"id":522,"nct":"NCT04488081","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-30","primary_completion_date":"2022-07-23","completion_date":"2022-10-31","first_posted_date":"2020-07-26"},{"id":521,"nct":"NCT04434131","title":"Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-27","primary_completion_date":"2021-04-27","completion_date":"2025-04-27","first_posted_date":"2020-06-15"},{"id":520,"nct":"NCT04348500","title":"Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19)","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-04-27","primary_completion_date":"2020-09-29","completion_date":"2020-09-29","first_posted_date":"2020-04-15"},{"id":519,"nct":"NCT04362332","title":"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-13","primary_completion_date":"2020-06-07","completion_date":"2020-06-07","first_posted_date":"2020-04-23"},{"id":518,"nct":"NCT04393038","title":"ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-06-30","primary_completion_date":"2021-03-04","completion_date":"2021-04-15","first_posted_date":"2020-05-18"},{"id":517,"nct":"NCT04547140","title":"Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-01-28","primary_completion_date":"2021-10-31","completion_date":"2022-01-31","first_posted_date":"2020-09-13"},{"id":516,"nct":"NCT04397718","title":"Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-05","primary_completion_date":"2021-06-07","completion_date":"2021-06-07","first_posted_date":"2020-05-20"},{"id":515,"nct":"NCT04411628","title":"A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19","status":"Completed","result":"Has Results","phases":"Phase 1","start_date":"2020-05-27","primary_completion_date":"2020-08-25","completion_date":"2020-08-25","first_posted_date":"2020-06-01"},{"id":514,"nct":"NCT04364763","title":"A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-04","primary_completion_date":"2021-12-30","completion_date":"2022-06-29","first_posted_date":"2020-04-27"},{"id":513,"nct":"NCT04433910","title":"A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-29","primary_completion_date":"2021-01-20","completion_date":"2021-02-21","first_posted_date":"2020-06-15"},{"id":512,"nct":"NCT04374279","title":"Trial to Promote Recovery From COVID-19 With Endocrine Therapy","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-12-31","completion_date":"2021-12-31","first_posted_date":"2020-05-04"},{"id":511,"nct":"NCT04397562","title":"A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-28","primary_completion_date":"2020-07-02","completion_date":"2020-08-02","first_posted_date":"2020-05-20"},{"id":510,"nct":"NCT04429711","title":"Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-05-11","primary_completion_date":"2020-09-29","completion_date":"2020-10-30","first_posted_date":"2020-06-11"},{"id":509,"nct":"NCT04405843","title":"Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)","status":"Completed","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-13","primary_completion_date":"2020-12-20","completion_date":"2020-12-20","first_posted_date":"2020-05-27"},{"id":508,"nct":"NCT04536090","title":"Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-12-31","primary_completion_date":"2022-11-30","completion_date":"2023-05-31","first_posted_date":"2020-09-01"},{"id":507,"nct":"NCT04432766","title":"A Phase 1\/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients","status":"Withdrawn","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-10-19","primary_completion_date":"2021-01-19","completion_date":"2021-08-17","first_posted_date":"2020-06-15"},{"id":506,"nct":"NCT04396106","title":"Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-25","primary_completion_date":"2022-05-31","completion_date":"2022-07-31","first_posted_date":"2020-05-19"},{"id":505,"nct":"NCT04601077","title":"The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-10-31","primary_completion_date":"2021-10-31","completion_date":"2021-12-30","first_posted_date":"2020-10-22"},{"id":504,"nct":"NCT04445935","title":"Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-06-27","primary_completion_date":"2020-09-27","completion_date":"2021-03-27","first_posted_date":"2020-06-23"},{"id":503,"nct":"NCT04709835","title":"Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2021-02-02","primary_completion_date":"2021-09-16","completion_date":"2021-10-12","first_posted_date":"2021-01-13"},{"id":502,"nct":"NCT04352465","title":"Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-04-30","primary_completion_date":"2020-06-29","completion_date":"2020-11-29","first_posted_date":"2020-04-19"},{"id":501,"nct":"NCT04679415","title":"Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-12-16","primary_completion_date":"2021-08-18","completion_date":"2021-08-18","first_posted_date":"2020-12-21"},{"id":500,"nct":"NCT04901676","title":"Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-09-08","primary_completion_date":"2021-12-31","completion_date":"2022-01-31","first_posted_date":"2021-05-24"},{"id":499,"nct":"NCT04474457","title":"Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age","status":"Active, not recruiting","result":"No Results Available","phases":null,"start_date":"2020-06-10","primary_completion_date":"2020-12-30","completion_date":"2021-05-31","first_posted_date":"2020-07-15"},{"id":498,"nct":"NCT04486313","title":"Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-08-12","primary_completion_date":"2021-02-07","completion_date":"2021-02-07","first_posted_date":"2020-07-23"},{"id":497,"nct":"NCT05003492","title":"Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2021-08-31","primary_completion_date":"2021-09-30","completion_date":"2021-10-31","first_posted_date":"2021-08-11"},{"id":496,"nct":"NCT04701658","title":"A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2021-01-31","primary_completion_date":"2021-06-21","completion_date":"2021-06-21","first_posted_date":"2021-01-07"},{"id":495,"nct":"NCT04351724","title":"Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-15","primary_completion_date":"2021-11-30","completion_date":"2022-03-30","first_posted_date":"2020-04-16"},{"id":494,"nct":"NCT04634409","title":"A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-28","primary_completion_date":"2021-07-26","completion_date":"2021-10-19","first_posted_date":"2020-11-17"},{"id":493,"nct":"NCT04429867","title":"Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-05-06","primary_completion_date":"2020-12-06","completion_date":"2020-12-06","first_posted_date":"2020-06-11"},{"id":492,"nct":"NCT04637828","title":"A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-17","primary_completion_date":"2021-07-29","completion_date":"2021-12-29","first_posted_date":"2020-11-19"},{"id":491,"nct":"NCT04492254","title":"Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-09-14","primary_completion_date":"2021-06-30","completion_date":"2021-08-31","first_posted_date":"2020-07-29"},{"id":490,"nct":"NCT04375046","title":"Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-06-30","primary_completion_date":"2021-07-31","completion_date":"2021-09-30","first_posted_date":"2020-05-04"},{"id":489,"nct":"NCT04358549","title":"Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-16","primary_completion_date":"2020-09-29","completion_date":"2020-10-29","first_posted_date":"2020-04-23"},{"id":488,"nct":"NCT04347954","title":"PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)","status":"Completed","result":"Has Results","phases":"Phase 1, Phase 2","start_date":"2020-08-14","primary_completion_date":"2020-12-12","completion_date":"2020-12-12","first_posted_date":"2020-04-14"},{"id":487,"nct":"NCT04891302","title":"The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-18","primary_completion_date":"2021-07-30","completion_date":"2021-10-30","first_posted_date":"2021-05-17"},{"id":486,"nct":"NCT04370236","title":"INB03 for the Treatment of Pulmonary Complications From COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-10-20","primary_completion_date":"2021-01-31","completion_date":"2021-01-31","first_posted_date":"2020-04-29"},{"id":485,"nct":"NCT04391127","title":"Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-03","primary_completion_date":"2020-11-05","completion_date":"2020-11-05","first_posted_date":"2020-05-17"},{"id":484,"nct":"NCT04941703","title":"\"CHANGE COVID-19 Severity\"","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2021-06-24","primary_completion_date":"2023-06-24","completion_date":"2024-06-29","first_posted_date":"2021-06-27"},{"id":483,"nct":"NCT04679350","title":"Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-17","primary_completion_date":"2021-11-29","completion_date":"2021-12-29","first_posted_date":"2020-12-21"},{"id":482,"nct":"NCT04776044","title":"Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-04-11","primary_completion_date":"2022-03-31","completion_date":"2022-05-31","first_posted_date":"2021-02-28"},{"id":481,"nct":"NCT04393311","title":"Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2022-01-31","primary_completion_date":"2022-07-31","completion_date":"2022-07-31","first_posted_date":"2020-05-18"},{"id":480,"nct":"NCT04410159","title":"Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-06-21","primary_completion_date":"2020-06-28","completion_date":"2020-07-05","first_posted_date":"2020-05-31"},{"id":479,"nct":"NCT04822701","title":"A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-04-20","primary_completion_date":"2021-07-01","completion_date":"2021-10-03","first_posted_date":"2021-03-29"},{"id":478,"nct":"NCT04463420","title":"Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-08-14","primary_completion_date":"2020-11-14","completion_date":"2020-12-14","first_posted_date":"2020-07-08"},{"id":477,"nct":"NCT04363216","title":"Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-30","primary_completion_date":"2021-04-30","completion_date":"2021-04-30","first_posted_date":"2020-04-26"},{"id":476,"nct":"NCT04621149","title":"An Outpatient Study Investigating Non-prescription Treatments for COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-14","primary_completion_date":"2021-03-30","completion_date":"2021-03-30","first_posted_date":"2020-11-08"},{"id":475,"nct":"NCT04351620","title":"High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-05-31","first_posted_date":"2020-04-16"},{"id":474,"nct":"NCT04552951","title":"Effect of Vitamin D on Morbidity and Mortality of the COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-03","primary_completion_date":"2020-09-13","completion_date":"2020-12-29","first_posted_date":"2020-09-16"},{"id":473,"nct":"NCT04355143","title":"Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-30","primary_completion_date":"2021-09-07","completion_date":"2021-09-07","first_posted_date":"2020-04-20"},{"id":472,"nct":"NCT04583592","title":"Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-08","primary_completion_date":"2021-03-30","completion_date":"2021-03-30","first_posted_date":"2020-10-11"},{"id":471,"nct":"NCT04421027","title":"A Study of Baricitinib (LY3009104) in Participants With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-11","primary_completion_date":"2021-02-11","completion_date":"2021-06-09","first_posted_date":"2020-06-08"},{"id":470,"nct":"NCT04372628","title":"Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-31","primary_completion_date":"2022-03-31","completion_date":"2022-05-31","first_posted_date":"2020-05-03"},{"id":469,"nct":"NCT04427865","title":"Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-06-30","primary_completion_date":"2020-08-31","completion_date":"2020-10-31","first_posted_date":"2020-06-10"},{"id":468,"nct":"NCT04412772","title":"Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-11","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2020-06-01"},{"id":467,"nct":"NCT04586153","title":"Study to Assess the Effect of Meplazumab on COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-02-14","primary_completion_date":"2022-05-30","completion_date":"2022-07-29","first_posted_date":"2020-10-13"},{"id":466,"nct":"NCT04354597","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"Withdrawn","result":"No Results Available","phases":"Not Applicable","start_date":"2020-04-30","primary_completion_date":"2020-08-14","completion_date":"2020-10-14","first_posted_date":"2020-04-20"},{"id":465,"nct":"NCT04361643","title":"Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-10-26","primary_completion_date":"2021-08-30","completion_date":"2021-12-30","first_posted_date":"2020-04-23"},{"id":464,"nct":"NCT04463602","title":"Desidustat in the Management of COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-24","primary_completion_date":"2021-01-24","completion_date":"2021-03-30","first_posted_date":"2020-07-08"},{"id":463,"nct":"NCT04480424","title":"Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-16","primary_completion_date":"2021-08-18","completion_date":"2021-10-24","first_posted_date":"2020-07-20"},{"id":462,"nct":"NCT04455243","title":"Inflammatory Regulation Effect of NAC on COVID-19 Treatment","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-07-31","primary_completion_date":"2021-08-29","completion_date":"2021-08-29","first_posted_date":"2020-07-01"},{"id":461,"nct":"NCT04394416","title":"Trial of Imatinib for Hospitalized Adults With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-01","primary_completion_date":"2022-05-31","completion_date":"2023-05-31","first_posted_date":"2020-05-18"},{"id":460,"nct":"NCT04992273","title":"COVID-19 Administration of Single-Dose Subcutaneous or Intramuscular Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-09-12","primary_completion_date":"2022-11-02","completion_date":"2022-11-02","first_posted_date":"2021-08-04"},{"id":459,"nct":"NCT04805671","title":"Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-07-25","primary_completion_date":"2021-12-31","completion_date":"2023-01-31","first_posted_date":"2021-03-17"},{"id":458,"nct":"NCT04444271","title":"Mesenchymal Stem Cell Infusion for COVID-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-30","primary_completion_date":"2020-08-29","completion_date":"2020-09-29","first_posted_date":"2020-06-22"},{"id":457,"nct":"NCT04374903","title":"Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2021-11-30","primary_completion_date":"2022-07-31","completion_date":"2022-08-31","first_posted_date":"2020-05-04"},{"id":456,"nct":"NCT04366050","title":"Ramipril for the Treatment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-10","primary_completion_date":"2021-04-30","completion_date":"2021-04-30","first_posted_date":"2020-04-27"},{"id":455,"nct":"NCT04801017","title":"A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-07-31","completion_date":"2021-09-30","first_posted_date":"2021-03-15"},{"id":454,"nct":"NCT04604327","title":"Comparison of Two Different Doses of Bemiparin in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-10-25","primary_completion_date":"2021-05-30","completion_date":"2021-07-30","first_posted_date":"2020-10-26"},{"id":453,"nct":"NCT05142527","title":"Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-11-30","primary_completion_date":"2023-03-31","completion_date":"2023-07-31","first_posted_date":"2021-12-01"},{"id":452,"nct":"NCT04666441","title":"COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-12-14","primary_completion_date":"2021-03-03","completion_date":"2021-09-20","first_posted_date":"2020-12-13"},{"id":451,"nct":"NCT05156645","title":"A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2022-01-14","primary_completion_date":"2022-11-30","completion_date":"2022-11-30","first_posted_date":"2021-12-13"},{"id":450,"nct":"NCT05130671","title":"Nutritional Supplementation of Vitamin D, Quercetin and Curcumin With Standard of Care for Managing Mild Early Symptoms of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2021-10-24","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2021-11-22"},{"id":449,"nct":"NCT04383002","title":"High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-09-01","primary_completion_date":"2021-05-10","completion_date":"2021-06-10","first_posted_date":"2020-05-10"},{"id":448,"nct":"NCT04890509","title":"A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-19","primary_completion_date":"2021-05-24","completion_date":"2021-05-24","first_posted_date":"2021-05-17"},{"id":447,"nct":"NCT04412252","title":"Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-05","primary_completion_date":"2020-09-15","completion_date":"2020-10-17","first_posted_date":"2020-06-01"},{"id":446,"nct":"NCT04443725","title":"Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-06-30","primary_completion_date":"2020-09-30","completion_date":"2020-11-30","first_posted_date":"2020-06-22"},{"id":445,"nct":"NCT04861298","title":"Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home","status":"Completed","result":"No Results Available","phases":"Not Applicable","start_date":"2021-01-10","primary_completion_date":"2021-08-28","completion_date":"2021-08-28","first_posted_date":"2021-04-26"},{"id":444,"nct":"NCT04412785","title":"Cyclosporine in Patients With Moderate COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-06-29","primary_completion_date":"2021-09-30","completion_date":"2021-11-30","first_posted_date":"2020-06-01"},{"id":443,"nct":"NCT04575610","title":"IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-26","primary_completion_date":"2021-10-05","completion_date":"2021-10-05","first_posted_date":"2020-10-04"},{"id":442,"nct":"NCT04356690","title":"Etoposide in Patients With COVID-19 Infection","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-07","primary_completion_date":"2021-11-30","completion_date":"2022-05-31","first_posted_date":"2020-04-21"},{"id":441,"nct":"NCT04922827","title":"Infliximab in the Treatment of Patients With Severe COVID-19 Disease","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-06-17","primary_completion_date":"2022-08-31","completion_date":"2023-06-30","first_posted_date":"2021-06-10"},{"id":440,"nct":"NCT04509999","title":"Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection","status":"Withdrawn","result":"No Results Available","phases":"Phase 3","start_date":"2020-10-25","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2020-08-11"},{"id":439,"nct":"NCT04415151","title":"Tofacitinib for Treatment of Moderate COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-13","primary_completion_date":"2021-02-27","completion_date":"2021-02-27","first_posted_date":"2020-06-03"},{"id":438,"nct":"NCT04667780","title":"Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-30","primary_completion_date":"2021-07-08","completion_date":"2021-07-08","first_posted_date":"2020-12-15"},{"id":437,"nct":"NCT04884490","title":"The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-05-14","primary_completion_date":"2021-10-13","completion_date":"2021-11-13","first_posted_date":"2021-05-12"},{"id":436,"nct":"NCT04351763","title":"Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms","status":"Completed","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-05-19","primary_completion_date":"2021-05-24","completion_date":"2021-06-04","first_posted_date":"2020-04-16"},{"id":435,"nct":"NCT04458298","title":"A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-10","primary_completion_date":"2022-06-01","completion_date":"2022-06-01","first_posted_date":"2020-07-06"},{"id":434,"nct":"NCT04354805","title":"Administration of Chlorpromazine as a Treatment for COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-31","primary_completion_date":"2020-09-30","completion_date":"2020-10-31","first_posted_date":"2020-04-20"},{"id":433,"nct":"NCT04731116","title":"Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2021-01-09","primary_completion_date":"2021-12-30","completion_date":"2022-04-29","first_posted_date":"2021-01-28"},{"id":432,"nct":"NCT04446377","title":"A Study of LAM-002A for the Prevention of Progression of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-14","primary_completion_date":"2021-03-30","completion_date":"2021-04-29","first_posted_date":"2020-06-23"},{"id":431,"nct":"NCT04941131","title":"The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2021-06-30","primary_completion_date":"2021-11-30","completion_date":"2022-02-28","first_posted_date":"2021-06-27"},{"id":430,"nct":"NCT04462757","title":"SCIL-1Ra in COVID-19 Feasibility & PK\/PD","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-27","primary_completion_date":"2020-08-30","completion_date":"2020-12-22","first_posted_date":"2020-07-07"},{"id":429,"nct":"NCT05088928","title":"Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2021-10-31","primary_completion_date":"2022-01-29","completion_date":"2022-08-29","first_posted_date":"2021-10-21"},{"id":428,"nct":"NCT04380402","title":"Atorvastatin as Adjunctive Therapy in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-24","primary_completion_date":"2021-12-30","completion_date":"2022-05-07","first_posted_date":"2020-05-07"},{"id":427,"nct":"NCT05164133","title":"A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2022-01-14","primary_completion_date":"2023-01-01","completion_date":"2023-01-01","first_posted_date":"2021-12-19"},{"id":426,"nct":"NCT05164120","title":"Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-12-13","primary_completion_date":"2022-03-31","completion_date":"2022-09-30","first_posted_date":"2021-12-19"},{"id":425,"nct":"NCT05156671","title":"Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-11-30","primary_completion_date":"2022-11-30","completion_date":"2023-05-31","first_posted_date":"2021-12-13"},{"id":424,"nct":"NCT04353284","title":"Camostat Mesylate in COVID-19 Outpatients","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-08","primary_completion_date":"2021-03-02","completion_date":"2021-04-21","first_posted_date":"2020-04-19"},{"id":423,"nct":"NCT04389710","title":"Convalescent Plasma for the Treatment of COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-14","primary_completion_date":"2020-11-02","completion_date":"2020-12-06","first_posted_date":"2020-05-14"},{"id":422,"nct":"NCT05135546","title":"Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-11-30","primary_completion_date":"2022-05-31","completion_date":"2022-12-30","first_posted_date":"2021-11-25"},{"id":421,"nct":"NCT05122260","title":"PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-11-10","primary_completion_date":"2021-12-14","completion_date":"2022-01-31","first_posted_date":"2021-11-15"},{"id":420,"nct":"NCT04400890","title":"Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-11","primary_completion_date":"2021-02-28","completion_date":"2021-02-28","first_posted_date":"2020-05-25"},{"id":419,"nct":"NCT04858633","title":"Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-03-21","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2021-04-25"},{"id":418,"nct":"NCT04365699","title":"Cardiovascular Effects of COVID-19","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-04-07","primary_completion_date":"2021-01-30","completion_date":"2021-01-30","first_posted_date":"2020-04-27"},{"id":417,"nct":"NCT04477642","title":"Abatacept for Patients With COVID-19 and Respiratory Distress","status":"Withdrawn","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-07-31","primary_completion_date":"2020-09-30","completion_date":"2020-11-30","first_posted_date":"2020-07-19"},{"id":416,"nct":"NCT05092503","title":"JINZHEN for Treatment of Mild to Moderate COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2021-12-31","primary_completion_date":"2022-11-30","completion_date":"2023-02-28","first_posted_date":"2021-10-24"},{"id":415,"nct":"NCT04382586","title":"Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-05","primary_completion_date":"2021-01-31","completion_date":"2021-01-31","first_posted_date":"2020-05-10"},{"id":414,"nct":"NCT04365725","title":"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections","status":"Completed","result":"No Results Available","phases":null,"start_date":"2020-05-04","primary_completion_date":"2020-06-11","completion_date":"2020-06-11","first_posted_date":"2020-04-27"},{"id":413,"nct":"NCT04369742","title":"Treating COVID-19 With Hydroxychloroquine (TEACH)","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-14","primary_completion_date":"2021-03-31","completion_date":"2021-03-31","first_posted_date":"2020-04-29"},{"id":412,"nct":"NCT04836052","title":"Omega-3 Oil Use in COVID-19 Patients in Qatar","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-12-23","primary_completion_date":"2021-08-23","completion_date":"2021-12-23","first_posted_date":"2021-04-07"},{"id":411,"nct":"NCT04667247","title":"Mushroom-based Product for COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-12-02","primary_completion_date":"2021-12-30","completion_date":"2022-11-30","first_posted_date":"2020-12-13"},{"id":410,"nct":"NCT04361214","title":"Leflunomide in Mild COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-05-04","primary_completion_date":"2021-01-31","completion_date":"2021-01-31","first_posted_date":"2020-04-23"},{"id":409,"nct":"NCT04389567","title":"Famotidine Outpatient COVID-19 Treatment Study","status":"Completed","result":"No Results Available","phases":null,"start_date":"2020-05-11","primary_completion_date":"2020-05-24","completion_date":"2020-05-24","first_posted_date":"2020-05-14"},{"id":408,"nct":"NCT04604184","title":"ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-02","primary_completion_date":"2021-03-23","completion_date":"2021-05-30","first_posted_date":"2020-10-26"},{"id":407,"nct":"NCT04473053","title":"DEFINE - Evaluating Therapies for COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-07-02","primary_completion_date":"2022-12-30","completion_date":"2022-12-30","first_posted_date":"2020-07-15"},{"id":406,"nct":"NCT04363372","title":"A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-31","primary_completion_date":"2020-11-30","completion_date":"2020-12-31","first_posted_date":"2020-04-26"},{"id":405,"nct":"NCT04350593","title":"Dapagliflozin in Respiratory Failure in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-21","primary_completion_date":"2021-03-30","completion_date":"2021-06-10","first_posted_date":"2020-04-16"},{"id":404,"nct":"NCT04952519","title":"Efficacy of Amantadine Treatment in COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-03-29","primary_completion_date":"2022-02-27","completion_date":"2022-04-29","first_posted_date":"2021-07-06"},{"id":403,"nct":"NCT04394442","title":"Hydroxychloroquine in COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-20","primary_completion_date":"2020-07-31","completion_date":"2020-07-31","first_posted_date":"2020-05-18"},{"id":402,"nct":"NCT04535869","title":"Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-12-27","primary_completion_date":"2021-03-31","completion_date":"2021-09-02","first_posted_date":"2020-09-01"},{"id":401,"nct":"NCT04664010","title":"Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)","status":"Active, not recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-02-05","primary_completion_date":"2021-01-13","completion_date":"2021-01-30","first_posted_date":"2020-12-10"},{"id":400,"nct":"NCT04501783","title":"Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-19","primary_completion_date":"2020-07-28","completion_date":"2020-07-31","first_posted_date":"2020-08-05"},{"id":399,"nct":"NCT04377620","title":"Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-23","primary_completion_date":"2021-02-25","completion_date":"2021-02-25","first_posted_date":"2020-05-05"},{"id":398,"nct":"NCT04708236","title":"A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia","status":"Withdrawn","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-04-30","completion_date":"2021-06-30","first_posted_date":"2021-01-12"},{"id":397,"nct":"NCT04475991","title":"Safety and Efficacy of Maraviroc and\/or Favipiravir With Standard Therapy in Severe COVID-19 Adults","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-07-12","primary_completion_date":"2021-09-30","completion_date":"2022-01-31","first_posted_date":"2020-07-16"},{"id":396,"nct":"NCT04352933","title":"PROLIFIC ChemoprophylaxisTrial (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-10","primary_completion_date":"2020-10-30","completion_date":"2021-03-31","first_posted_date":"2020-04-19"},{"id":395,"nct":"NCT04435184","title":"Crizanlizumab for Treating COVID-19 Vasculopathy","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-07-08","primary_completion_date":"2020-11-27","completion_date":"2021-01-03","first_posted_date":"2020-06-16"},{"id":394,"nct":"NCT04389359","title":"PROphylaxis for paTiEnts at Risk of COVID-19 infecTion","status":"Withdrawn","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-08-31","primary_completion_date":"2021-07-31","completion_date":"2025-07-31","first_posted_date":"2020-05-14"},{"id":393,"nct":"NCT04354714","title":"Ruxolitinib to Combat COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-29","primary_completion_date":"2021-07-30","completion_date":"2021-12-30","first_posted_date":"2020-04-20"},{"id":392,"nct":"NCT04441385","title":"Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-25","primary_completion_date":"2020-11-29","completion_date":"2020-12-19","first_posted_date":"2020-06-21"},{"id":391,"nct":"NCT04416048","title":"Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-29","primary_completion_date":"2021-12-30","completion_date":"2022-01-30","first_posted_date":"2020-06-03"},{"id":390,"nct":"NCT05118737","title":"Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.","status":"Recruiting","result":"No Results Available","phases":"Early Phase 1","start_date":"2021-09-30","primary_completion_date":"2022-04-29","completion_date":"2022-08-29","first_posted_date":"2021-11-11"},{"id":389,"nct":"NCT04468087","title":"Antiviral Agents Against COVID-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-02-14","primary_completion_date":"2021-11-27","completion_date":"2022-02-27","first_posted_date":"2020-07-12"},{"id":388,"nct":"NCT04456153","title":"Atovaquone for Treatment of COVID-19","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-07-21","primary_completion_date":"2021-01-30","completion_date":"2021-01-30","first_posted_date":"2020-07-01"},{"id":387,"nct":"NCT04362943","title":"Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults","status":"Completed","result":"No Results Available","phases":null,"start_date":"2020-04-19","primary_completion_date":"2021-04-14","completion_date":"2021-04-14","first_posted_date":"2020-04-26"},{"id":386,"nct":"NCT04399356","title":"Niclosamide for Mild to Moderate COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-30","primary_completion_date":"2021-04-19","completion_date":"2021-08-18","first_posted_date":"2020-05-21"},{"id":385,"nct":"NCT04681079","title":"Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19","status":"Recruiting","result":"No Results Available","phases":null,"start_date":"2021-05-03","primary_completion_date":"2021-11-30","completion_date":"2021-11-30","first_posted_date":"2020-12-22"},{"id":384,"nct":"NCT04920942","title":"Ivermectin Treatment Efficacy in Covid-19 High Risk Patients","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2021-05-30","primary_completion_date":"2021-10-30","completion_date":"2021-10-30","first_posted_date":"2021-06-09"},{"id":383,"nct":"NCT04366739","title":"Repurposing of Chlorpromazine in Covid-19 Treatment","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-28","primary_completion_date":"2020-08-29","completion_date":"2020-09-29","first_posted_date":"2020-04-28"},{"id":382,"nct":"NCT04828161","title":"A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-05-23","primary_completion_date":"2022-04-30","completion_date":"2022-05-31","first_posted_date":"2021-03-31"},{"id":381,"nct":"NCT04466540","title":"Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-05-11","primary_completion_date":"2021-07-27","completion_date":"2021-08-27","first_posted_date":"2020-07-09"},{"id":380,"nct":"NCT04350671","title":"Interferon Beta 1a in Hospitalized COVID-19 Patients","status":"Enrolling by invitation","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-14","primary_completion_date":"2020-04-19","completion_date":"2020-04-23","first_posted_date":"2020-04-16"},{"id":379,"nct":"NCT05007678","title":"Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-09-15","primary_completion_date":"2022-06-30","completion_date":"2022-06-30","first_posted_date":"2021-08-15"},{"id":378,"nct":"NCT04390594","title":"Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-08-12","primary_completion_date":"2021-02-11","completion_date":"2021-08-11","first_posted_date":"2020-05-14"},{"id":377,"nct":"NCT04346199","title":"Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-06-11","primary_completion_date":"2020-11-16","completion_date":"2020-11-16","first_posted_date":"2020-04-14"},{"id":376,"nct":"NCT04350684","title":"Umifenovir in Hospitalized COVID-19 Patients","status":"Enrolling by invitation","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-14","primary_completion_date":"2020-04-21","completion_date":"2020-04-23","first_posted_date":"2020-04-16"},{"id":375,"nct":"NCT04870164","title":"Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-11-17","primary_completion_date":"2021-12-31","completion_date":"2021-12-31","first_posted_date":"2021-05-02"},{"id":374,"nct":"NCT04380688","title":"Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-06-12","primary_completion_date":"2020-11-15","completion_date":"2020-11-15","first_posted_date":"2020-05-07"},{"id":373,"nct":"NCT04363346","title":"Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-05-13","primary_completion_date":"2021-12-31","completion_date":"2021-12-31","first_posted_date":"2020-04-26"},{"id":372,"nct":"NCT04466670","title":"Hemostasis in COVID-19: an Adaptive Clinical Trial","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-10","primary_completion_date":"2021-12-29","completion_date":"2022-05-29","first_posted_date":"2020-07-09"},{"id":371,"nct":"NCT04381884","title":"Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-17","primary_completion_date":"2020-09-28","completion_date":"2020-09-28","first_posted_date":"2020-05-10"},{"id":370,"nct":"NCT04397328","title":"COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-18","primary_completion_date":"2021-04-29","completion_date":"2021-04-29","first_posted_date":"2020-05-20"},{"id":369,"nct":"NCT04603794","title":"Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-09-30","primary_completion_date":"2020-10-31","completion_date":"2020-10-31","first_posted_date":"2020-10-26"},{"id":368,"nct":"NCT04583956","title":"ACTIV-5 \/ Big Effect Trial (BET-A) for the Treatment of COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-13","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2020-10-11"},{"id":367,"nct":"NCT04355936","title":"Telmisartan for Treatment of COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2020-05-18","primary_completion_date":"2020-11-01","completion_date":"2020-11-29","first_posted_date":"2020-04-20"},{"id":366,"nct":"NCT04359953","title":"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-24","primary_completion_date":"2022-03-31","completion_date":"2022-03-31","first_posted_date":"2020-04-23"},{"id":365,"nct":"NCT04934111","title":"Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-08-31","primary_completion_date":"2022-05-31","completion_date":"2022-07-31","first_posted_date":"2021-06-21"},{"id":364,"nct":"NCT04603924","title":"Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-10-06","primary_completion_date":"2021-11-30","completion_date":"2022-05-31","first_posted_date":"2020-10-26"},{"id":363,"nct":"NCT04475107","title":"The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-08","primary_completion_date":"2021-03-24","completion_date":"2021-04-14","first_posted_date":"2020-07-16"},{"id":362,"nct":"NCT04514302","title":"Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab\\')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-10-26","primary_completion_date":"2022-02-19","completion_date":"2022-02-19","first_posted_date":"2020-08-13"},{"id":361,"nct":"NCT04497948","title":"Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19","status":"Terminated","result":"Has Results","phases":"Phase 1","start_date":"2020-09-20","primary_completion_date":"2020-11-17","completion_date":"2020-11-17","first_posted_date":"2020-08-03"},{"id":360,"nct":"NCT04364815","title":"The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial","status":"Withdrawn","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-30","primary_completion_date":"2021-04-30","completion_date":"2021-04-30","first_posted_date":"2020-04-27"},{"id":359,"nct":"NCT04647604","title":"Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-22","primary_completion_date":"2021-04-29","completion_date":"2021-04-29","first_posted_date":"2020-11-30"},{"id":358,"nct":"NCT05069649","title":"Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-10-05","primary_completion_date":"2022-12-30","completion_date":"2022-12-30","first_posted_date":"2021-10-05"},{"id":357,"nct":"NCT04640168","title":"Adaptive COVID-19 Treatment Trial 4 (ACTT-4)","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-23","primary_completion_date":"2021-05-17","completion_date":"2021-06-17","first_posted_date":"2020-11-22"},{"id":356,"nct":"NCT04532931","title":"COVID-19 Treatment in South Africa","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-02","primary_completion_date":"2021-08-04","completion_date":"2021-08-22","first_posted_date":"2020-08-30"},{"id":355,"nct":"NCT04511819","title":"Losmapimod Safety and Efficacy in COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-08-27","primary_completion_date":"2021-03-30","completion_date":"2021-03-30","first_posted_date":"2020-08-12"},{"id":354,"nct":"NCT04382781","title":"Immunosupressive Treatment in COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":null,"start_date":"2020-04-30","primary_completion_date":"2020-04-30","completion_date":"2020-04-30","first_posted_date":"2020-05-10"},{"id":353,"nct":"NCT04428008","title":"Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-01-11","primary_completion_date":"2021-07-31","completion_date":"2022-04-30","first_posted_date":"2020-06-10"},{"id":352,"nct":"NCT04988035","title":"ACTIV-5 \/ Big Effect Trial (BET-C) for the Treatment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-07-20","primary_completion_date":"2022-10-30","completion_date":"2022-12-21","first_posted_date":"2021-08-02"},{"id":351,"nct":"NCT04935476","title":"Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-11-21","primary_completion_date":"2022-03-30","completion_date":"2022-07-30","first_posted_date":"2021-06-22"},{"id":350,"nct":"NCT04348071","title":"Safety and Efficacy of Ruxolitinib for COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-06-30","primary_completion_date":"2021-07-31","completion_date":"2021-09-30","first_posted_date":"2020-04-14"},{"id":349,"nct":"NCT04401579","title":"Adaptive COVID-19 Treatment Trial 2 (ACTT-2)","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-05-07","primary_completion_date":"2020-07-30","completion_date":"2020-07-30","first_posted_date":"2020-05-25"},{"id":348,"nct":"NCT04359316","title":"Azithromycin in Hospitalized COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-19","primary_completion_date":"2020-05-02","completion_date":"2020-05-04","first_posted_date":"2020-04-23"},{"id":347,"nct":"NCT04583969","title":"ACTIV-5 \/ Big Effect Trial (BET-B) for the Treatment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-18","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2020-10-11"},{"id":346,"nct":"NCT04359615","title":"Favipiravir in Hospitalized COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-19","primary_completion_date":"2020-05-02","completion_date":"2020-05-04","first_posted_date":"2020-04-23"},{"id":345,"nct":"NCT05084911","title":"The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-10-17","primary_completion_date":"2022-06-29","completion_date":"2022-09-29","first_posted_date":"2021-10-19"},{"id":344,"nct":"NCT04492475","title":"Adaptive COVID-19 Treatment Trial 3 (ACTT-3)","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-08-04","primary_completion_date":"2020-12-20","completion_date":"2020-12-20","first_posted_date":"2020-07-29"},{"id":343,"nct":"NCT04385043","title":"Hyperimmune Plasma in Patients With COVID-19 Severe Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-30","primary_completion_date":"2020-10-14","completion_date":"2021-05-14","first_posted_date":"2020-05-11"},{"id":342,"nct":"NCT04432324","title":"Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-01","primary_completion_date":"2021-03-02","completion_date":"2021-03-02","first_posted_date":"2020-06-15"},{"id":341,"nct":"NCT04542694","title":"Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-05-20","primary_completion_date":"2020-08-09","completion_date":"2020-08-19","first_posted_date":"2020-09-08"},{"id":340,"nct":"NCT04443270","title":"Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-07-26","primary_completion_date":"2020-10-30","completion_date":"2021-01-30","first_posted_date":"2020-06-22"},{"id":339,"nct":"NCT04432298","title":"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-19","primary_completion_date":"2021-03-21","completion_date":"2021-03-21","first_posted_date":"2020-06-15"},{"id":338,"nct":"NCT04504032","title":"A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)","status":"Terminated","result":"Has Results","phases":"Phase 2","start_date":"2020-09-01","primary_completion_date":"2021-03-09","completion_date":"2021-03-28","first_posted_date":"2020-08-06"},{"id":337,"nct":"NCT04426695","title":"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-06-10","primary_completion_date":"2021-05-06","completion_date":"2021-10-21","first_posted_date":"2020-06-10"},{"id":336,"nct":"NCT04433013","title":"A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-30","primary_completion_date":"2020-11-30","completion_date":"2021-01-31","first_posted_date":"2020-06-15"},{"id":335,"nct":"NCT04354389","title":"DAS181 for STOP COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-24","primary_completion_date":"2020-09-29","completion_date":"2020-11-29","first_posted_date":"2020-04-20"},{"id":334,"nct":"NCT04410354","title":"Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-15","primary_completion_date":"2020-11-30","completion_date":"2020-11-30","first_posted_date":"2020-05-31"},{"id":333,"nct":"NCT04381052","title":"Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-17","primary_completion_date":"2021-02-02","completion_date":"2021-03-11","first_posted_date":"2020-05-07"},{"id":332,"nct":"NCT04681053","title":"Inhaled Ivermectin and COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-02-24","primary_completion_date":"2021-04-29","completion_date":"2021-12-30","first_posted_date":"2020-12-22"},{"id":331,"nct":"NCT04495101","title":"Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-28","primary_completion_date":"2021-04-25","completion_date":"2021-06-09","first_posted_date":"2020-07-30"},{"id":330,"nct":"NCT04464408","title":"Favipiravir Therapy in Adults With Mild COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-07-22","primary_completion_date":"2021-08-03","completion_date":"2021-08-03","first_posted_date":"2020-07-08"},{"id":329,"nct":"NCT05126628","title":"The South Proxa-Rescue AndroCoV Trial Against COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2021-03-05","primary_completion_date":"2021-03-15","completion_date":"2021-04-14","first_posted_date":"2021-11-18"},{"id":328,"nct":"NCT04375202","title":"Colchicine in COVID-19: a Pilot Study","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-17","primary_completion_date":"2022-10-30","completion_date":"2022-10-30","first_posted_date":"2020-05-04"},{"id":327,"nct":"NCT05082714","title":"Tocilizumab Versus Baricitinib in Patients With Severe COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2021-10-17","primary_completion_date":"2022-03-31","completion_date":"2022-03-31","first_posted_date":"2021-10-18"},{"id":326,"nct":"NCT04405102","title":"COVID-19 Ozanimod Intervention Study","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-15","primary_completion_date":"2022-12-31","completion_date":"2023-12-31","first_posted_date":"2020-05-27"},{"id":325,"nct":"NCT04465695","title":"Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-13","primary_completion_date":"2021-06-29","completion_date":"2021-09-29","first_posted_date":"2020-07-09"},{"id":324,"nct":"NCT05122234","title":"Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-08-09","primary_completion_date":"2021-07-29","completion_date":"2021-11-13","first_posted_date":"2021-11-15"},{"id":323,"nct":"NCT04382066","title":"Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19","status":"Completed","result":"Has Results","phases":"Phase 1","start_date":"2020-05-11","primary_completion_date":"2020-11-25","completion_date":"2020-11-25","first_posted_date":"2020-05-10"},{"id":322,"nct":"NCT04715295","title":"Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-10-04","primary_completion_date":"2021-05-29","completion_date":"2021-09-04","first_posted_date":"2021-01-19"},{"id":321,"nct":"NCT04550338","title":"Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure","status":"Withdrawn","result":"No Results Available","phases":"Phase 3","start_date":"2021-07-31","primary_completion_date":"2022-12-30","completion_date":"2023-03-30","first_posted_date":"2020-09-15"},{"id":320,"nct":"NCT05125562","title":"Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-05-06","primary_completion_date":"2022-08-06","completion_date":"2022-08-06","first_posted_date":"2021-11-17"},{"id":319,"nct":"NCT04960202","title":"EPIC-HR: Study of Oral PF-07321332\/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-07-15","primary_completion_date":"2021-12-08","completion_date":"2022-04-20","first_posted_date":"2021-07-12"},{"id":318,"nct":"NCT04364022","title":"Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-22","primary_completion_date":"2021-03-23","completion_date":"2021-03-23","first_posted_date":"2020-04-26"},{"id":317,"nct":"NCT04646109","title":"Ivermectin for Severe COVID-19 Management","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-05-10","primary_completion_date":"2020-09-01","completion_date":"2020-09-01","first_posted_date":"2020-11-26"},{"id":316,"nct":"NCT04668235","title":"Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-04-22","primary_completion_date":"2021-10-31","completion_date":"2021-11-30","first_posted_date":"2020-12-15"},{"id":315,"nct":"NCT04808882","title":"ANTIcoagulation in Severe COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-04-13","primary_completion_date":"2021-11-30","completion_date":"2022-01-31","first_posted_date":"2021-03-21"},{"id":314,"nct":"NCT05047601","title":"A Post-Exposure Prophylaxis Study of PF-07321332\/Ritonavir in Adult Household Contacts of an Individual With Symptomatic COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-09-08","primary_completion_date":"2022-03-01","completion_date":"2022-03-01","first_posted_date":"2021-09-16"},{"id":313,"nct":"NCT04527133","title":"An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-06-10","primary_completion_date":"2020-08-10","completion_date":"2020-08-30","first_posted_date":"2020-08-25"},{"id":312,"nct":"NCT04928495","title":"Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-07-14","primary_completion_date":"2022-04-08","completion_date":"2022-06-08","first_posted_date":"2021-06-15"},{"id":311,"nct":"NCT04425629","title":"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-06-15","primary_completion_date":"2021-12-28","completion_date":"2022-05-17","first_posted_date":"2020-06-10"},{"id":310,"nct":"NCT04784897","title":"A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2021-02-21","primary_completion_date":"2021-06-30","completion_date":"2021-07-29","first_posted_date":"2021-03-04"},{"id":309,"nct":"NCT04467151","title":"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-30","primary_completion_date":"2021-09-30","completion_date":"2021-11-30","first_posted_date":"2020-07-09"},{"id":308,"nct":"NCT04880109","title":"A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-10-19","primary_completion_date":"2023-01-31","completion_date":"2023-02-28","first_posted_date":"2021-05-09"},{"id":307,"nct":"NCT04784754","title":"Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-03-31","primary_completion_date":"2021-09-29","completion_date":"2021-12-30","first_posted_date":"2021-03-04"},{"id":306,"nct":"NCT04464395","title":"Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients","status":"Completed","result":"No Results Available","phases":"Phase 1","start_date":"2020-06-30","primary_completion_date":"2021-02-28","completion_date":"2021-07-08","first_posted_date":"2020-07-08"},{"id":305,"nct":"NCT04372979","title":"Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-09-13","primary_completion_date":"2021-04-30","completion_date":"2021-05-31","first_posted_date":"2020-05-03"},{"id":304,"nct":"NCT04434248","title":"An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-22","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-06-15"},{"id":303,"nct":"NCT04619706","title":"Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-12-13","primary_completion_date":"2021-08-13","completion_date":"2021-12-04","first_posted_date":"2020-11-05"},{"id":302,"nct":"NCT04376788","title":"Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-19","primary_completion_date":"2020-06-30","completion_date":"2020-08-31","first_posted_date":"2020-05-05"},{"id":301,"nct":"NCT04445272","title":"Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-21","primary_completion_date":"2020-12-22","completion_date":"2020-12-22","first_posted_date":"2020-06-23"},{"id":300,"nct":"NCT04733833","title":"A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-01-25","primary_completion_date":"2022-06-29","completion_date":"2022-06-29","first_posted_date":"2021-02-01"},{"id":299,"nct":"NCT05011513","title":"Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-08-24","primary_completion_date":"2021-12-11","completion_date":"2022-04-23","first_posted_date":"2021-08-17"},{"id":298,"nct":"NCT04590586","title":"Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-23","primary_completion_date":"2021-08-02","completion_date":"2021-08-02","first_posted_date":"2020-10-18"},{"id":297,"nct":"NCT04370262","title":"Multi-site Adaptive Trials for COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-06","primary_completion_date":"2020-09-06","completion_date":"2020-09-06","first_posted_date":"2020-04-29"},{"id":296,"nct":"NCT05092581","title":"COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-12-19","primary_completion_date":"2023-06-08","completion_date":"2023-06-08","first_posted_date":"2021-10-24"},{"id":295,"nct":"NCT05157243","title":"Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-12-31","primary_completion_date":"2022-03-31","completion_date":"2022-04-30","first_posted_date":"2021-12-13"},{"id":294,"nct":"NCT04392141","title":"Colchicine Plus Phenolic Monoterpenes to Treat COVID-19","status":"Completed","result":"Has Results","phases":"Phase 1, Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-10-31","completion_date":"2020-10-31","first_posted_date":"2020-05-17"},{"id":293,"nct":"NCT05157269","title":"Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-12-31","primary_completion_date":"2022-02-28","completion_date":"2022-03-31","first_posted_date":"2021-12-13"},{"id":292,"nct":"NCT05155527","title":"A Double-blind Randomized Controlled Trial of Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-11-30","primary_completion_date":"2022-05-31","completion_date":"2022-05-31","first_posted_date":"2021-12-12"},{"id":291,"nct":"NCT04401423","title":"TXA127 for the Treatment of Severe COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2021-02-09","primary_completion_date":"2021-06-09","completion_date":"2021-06-09","first_posted_date":"2020-05-25"},{"id":290,"nct":"NCT04342689","title":"The Role of Resistant Starch in COVID-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-06-02","primary_completion_date":"2022-02-28","completion_date":"2022-02-28","first_posted_date":"2020-04-12"},{"id":289,"nct":"NCT04479358","title":"Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-09","primary_completion_date":"2022-02-28","completion_date":"2023-02-28","first_posted_date":"2020-07-20"},{"id":288,"nct":"NCT05041907","title":"Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-09-29","primary_completion_date":"2023-07-31","completion_date":"2023-07-31","first_posted_date":"2021-09-12"},{"id":287,"nct":"NCT04853069","title":"Oestrogen Treatment for COVID-19 Symptoms","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-05-16","primary_completion_date":"2022-02-27","completion_date":"2022-03-30","first_posted_date":"2021-04-20"},{"id":286,"nct":"NCT04716426","title":"APT\u2122 T3X on the COVID-19 Contamination Rate","status":"Completed","result":"Has Results","phases":"Not Applicable","start_date":"2021-01-27","primary_completion_date":"2021-03-24","completion_date":"2021-03-24","first_posted_date":"2021-01-19"},{"id":285,"nct":"NCT04474483","title":"Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-11-05","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2020-07-15"},{"id":284,"nct":"NCT04482621","title":"Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-13","primary_completion_date":"2022-01-31","completion_date":"2022-02-28","first_posted_date":"2020-07-21"},{"id":283,"nct":"NCT04757857","title":"COVID-19 Antithrombotic Rivaroxaban Evaluation","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-09-28","primary_completion_date":"2021-09-27","completion_date":"2021-10-29","first_posted_date":"2021-02-16"},{"id":282,"nct":"NCT04928430","title":"Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-04-27","primary_completion_date":"2022-03-31","completion_date":"2022-03-31","first_posted_date":"2021-06-15"},{"id":281,"nct":"NCT04770467","title":"A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2021-01-31","primary_completion_date":"2022-09-30","completion_date":"2022-09-30","first_posted_date":"2021-02-24"},{"id":280,"nct":"NCT04534673","title":"Pegylated Interferon Lambda for Treatment of COVID-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-08-04","primary_completion_date":"2021-12-30","completion_date":"2021-12-30","first_posted_date":"2020-08-31"},{"id":279,"nct":"NCT04780672","title":"Clinical Study in the Treatment of Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-03-08","primary_completion_date":"2022-05-30","completion_date":"2022-09-29","first_posted_date":"2021-03-02"},{"id":278,"nct":"NCT04842435","title":"Clinical Study in the Treatment of Patients With Moderate Course of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-04-11","primary_completion_date":"2021-09-29","completion_date":"2021-10-04","first_posted_date":"2021-04-12"},{"id":277,"nct":"NCT04406389","title":"Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-10-12","primary_completion_date":"2022-05-31","completion_date":"2022-11-30","first_posted_date":"2020-05-27"},{"id":276,"nct":"NCT04854928","title":"Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-05-02","primary_completion_date":"2022-01-31","completion_date":"2022-04-30","first_posted_date":"2021-04-21"},{"id":275,"nct":"NCT04452669","title":"VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-09-14","primary_completion_date":"2021-06-28","completion_date":"2021-06-28","first_posted_date":"2020-06-29"},{"id":274,"nct":"NCT04523090","title":"Catalysing the Containment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-08-26","primary_completion_date":"2021-11-30","completion_date":"2022-01-31","first_posted_date":"2020-08-20"},{"id":273,"nct":"NCT04889040","title":"Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-04-27","primary_completion_date":"2021-11-16","completion_date":"2021-11-16","first_posted_date":"2021-05-16"},{"id":272,"nct":"NCT04470622","title":"Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-07-19","primary_completion_date":"2021-04-08","completion_date":"2021-06-02","first_posted_date":"2020-07-13"},{"id":271,"nct":"NCT04347915","title":"The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-05","primary_completion_date":"2021-01-29","completion_date":"2021-03-30","first_posted_date":"2020-04-14"},{"id":270,"nct":"NCT04625725","title":"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-20","primary_completion_date":"2021-05-04","completion_date":"2022-06-28","first_posted_date":"2020-11-11"},{"id":269,"nct":"NCT04501796","title":"A Trial of NT-I7 in COVID-19 (SPESELPIS)","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-11-26","primary_completion_date":"2022-02-28","completion_date":"2022-05-31","first_posted_date":"2020-08-05"},{"id":268,"nct":"NCT04421534","title":"Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-05-31","primary_completion_date":"2020-08-31","completion_date":"2020-10-31","first_posted_date":"2020-06-08"},{"id":267,"nct":"NCT05126576","title":"Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19","status":"Suspended","result":"No Results Available","phases":"Phase 3","start_date":"2021-04-27","primary_completion_date":"2021-11-16","completion_date":"2021-11-16","first_posted_date":"2021-11-18"},{"id":266,"nct":"NCT04932941","title":"MP1032 Treatment in Patients With Moderate to Severe COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-08-31","primary_completion_date":"2022-02-28","completion_date":"2022-02-28","first_posted_date":"2021-06-20"},{"id":265,"nct":"NCT04578158","title":"Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-09-28","primary_completion_date":"2021-03-27","completion_date":"2021-04-14","first_posted_date":"2020-10-07"},{"id":264,"nct":"NCT04388683","title":"Inhaled Nitric Oxide for Preventing Progression in COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-11","primary_completion_date":"2020-11-22","completion_date":"2020-11-22","first_posted_date":"2020-05-13"},{"id":263,"nct":"NCT04625972","title":"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-12-01","primary_completion_date":"2021-04-06","completion_date":"2022-06-18","first_posted_date":"2020-11-11"},{"id":262,"nct":"NCT04361422","title":"Isotretinoin in Treatment of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-11-30","primary_completion_date":"2021-07-31","completion_date":"2021-11-30","first_posted_date":"2020-04-23"},{"id":261,"nct":"NCT04460547","title":"Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic","status":"Not yet recruiting","result":"No Results Available","phases":null,"start_date":"2020-07-24","primary_completion_date":"2020-08-14","completion_date":"2020-09-19","first_posted_date":"2020-07-06"},{"id":260,"nct":"NCT04359095","title":"Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia","status":"Completed","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-08-17","primary_completion_date":"2021-03-19","completion_date":"2021-06-29","first_posted_date":"2020-04-23"},{"id":259,"nct":"NCT04883138","title":"Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2021-05-23","primary_completion_date":"2021-08-14","completion_date":"2021-08-29","first_posted_date":"2021-05-11"},{"id":258,"nct":"NCT04723394","title":"Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-01-27","primary_completion_date":"2021-08-20","completion_date":"2022-10-20","first_posted_date":"2021-01-24"},{"id":257,"nct":"NCT04582266","title":"PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US","status":"Recruiting","result":"No Results Available","phases":null,"start_date":"2021-02-11","primary_completion_date":"2022-01-14","completion_date":"2022-01-14","first_posted_date":"2020-10-08"},{"id":256,"nct":"NCT05074394","title":"Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS\u2122) in Outpatient Adults With Mild COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2021-10-31","primary_completion_date":"2022-10-31","completion_date":"2022-12-31","first_posted_date":"2021-10-11"},{"id":255,"nct":"NCT04568031","title":"Study of AZD1222 for the Prevention of COVID-19 in Japan","status":"Completed","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-08-22","primary_completion_date":"2021-11-21","completion_date":"2021-11-21","first_posted_date":"2020-09-28"},{"id":254,"nct":"NCT04869228","title":"A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2021-08-03","primary_completion_date":"2022-02-27","completion_date":"2022-05-29","first_posted_date":"2021-05-02"},{"id":253,"nct":"NCT04628143","title":"A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-12-20","primary_completion_date":"2021-04-04","completion_date":"2021-04-04","first_posted_date":"2020-11-12"},{"id":252,"nct":"NCT04432987","title":"Dornase Alpha for the Treatment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-05-24","primary_completion_date":"2020-08-24","completion_date":"2020-09-24","first_posted_date":"2020-06-15"},{"id":251,"nct":"NCT04452435","title":"Safety and Efficacy of C21 in Subjects With COVID-19","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-07-20","primary_completion_date":"2020-10-12","completion_date":"2020-10-12","first_posted_date":"2020-06-29"},{"id":250,"nct":"NCT04454307","title":"Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-06-30","primary_completion_date":"2020-07-31","completion_date":"2020-09-30","first_posted_date":"2020-06-30"},{"id":249,"nct":"NCT04425538","title":"A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-05-31","primary_completion_date":"2021-01-21","completion_date":"2021-01-21","first_posted_date":"2020-06-10"},{"id":248,"nct":"NCT04372602","title":"Duvelisib to Combat COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-10-11","primary_completion_date":"2021-11-29","completion_date":"2022-04-29","first_posted_date":"2020-05-03"},{"id":247,"nct":"NCT04308668","title":"Post-exposure Prophylaxis \/ Preemptive Therapy for SARS-Coronavirus-2","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-16","primary_completion_date":"2020-04-20","completion_date":"2020-05-11","first_posted_date":"2020-03-15"},{"id":246,"nct":"NCT03680274","title":"Lessening Organ Dysfunction With VITamin C","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2018-11-07","primary_completion_date":"2021-12-30","completion_date":"2022-12-30","first_posted_date":"2018-09-20"},{"id":245,"nct":"NCT04276688","title":"Lopinavir\/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-09","primary_completion_date":"2022-01-30","completion_date":"2022-07-30","first_posted_date":"2020-02-18"},{"id":244,"nct":"NCT04316377","title":"Norwegian Coronavirus Disease 2019 Study","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-24","primary_completion_date":"2021-03-31","completion_date":"2025-03-02","first_posted_date":"2020-03-19"},{"id":243,"nct":"NCT04244591","title":"Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-01-25","primary_completion_date":"2020-04-24","completion_date":"2020-12-24","first_posted_date":"2020-01-27"},{"id":242,"nct":"NCT04328467","title":"Pre-exposure Prophylaxis for SARS-Coronavirus-2","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-05","primary_completion_date":"2020-07-31","completion_date":"2020-07-31","first_posted_date":"2020-03-30"},{"id":241,"nct":"NCT04331808","title":"CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-30","primary_completion_date":"2021-03-30","completion_date":"2021-12-30","first_posted_date":"2020-04-01"},{"id":240,"nct":"NCT04341727","title":"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-03","primary_completion_date":"2021-03-31","completion_date":"2021-07-31","first_posted_date":"2020-04-09"},{"id":239,"nct":"NCT04275245","title":"Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-02-02","primary_completion_date":"2020-12-30","completion_date":"2020-12-30","first_posted_date":"2020-02-18"},{"id":238,"nct":"NCT04251871","title":"Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-01-21","primary_completion_date":"2021-01-21","completion_date":"2021-01-21","first_posted_date":"2020-02-04"},{"id":237,"nct":"NCT04322682","title":"Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-22","primary_completion_date":"2020-08-31","completion_date":"2020-08-31","first_posted_date":"2020-03-25"},{"id":236,"nct":"NCT03331445","title":"Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2017-10-23","primary_completion_date":"2020-12-30","completion_date":"2021-03-30","first_posted_date":"2017-11-05"},{"id":235,"nct":"NCT04302766","title":"Expanded Access Remdesivir (RDV; GS-5734\u2122)","status":"Available","result":"No Results Available","phases":"","start_date":null,"primary_completion_date":null,"completion_date":null,"first_posted_date":"2020-03-09"},{"id":234,"nct":"NCT04275388","title":"Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-02-13","primary_completion_date":"2020-05-13","completion_date":"2021-12-13","first_posted_date":"2020-02-18"},{"id":233,"nct":"NCT04323527","title":"Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-22","primary_completion_date":"2020-08-30","completion_date":"2020-08-30","first_posted_date":"2020-03-25"},{"id":232,"nct":"NCT04264533","title":"Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-13","primary_completion_date":"2020-09-29","completion_date":"2020-09-29","first_posted_date":"2020-02-10"},{"id":231,"nct":"NCT04261907","title":"Evaluating and Comparing the Safety and Efficiency of ASC09\/Ritonavir and Lopinavir\/Ritonavir for Novel Coronavirus Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-02-06","primary_completion_date":"2020-05-30","completion_date":"2020-06-29","first_posted_date":"2020-02-09"},{"id":230,"nct":"NCT04340557","title":"Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-26","primary_completion_date":"2020-10-05","completion_date":"2020-12-30","first_posted_date":"2020-04-08"},{"id":229,"nct":"NCT04341584","title":"CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-04-30","completion_date":"2020-12-30","first_posted_date":"2020-04-09"},{"id":228,"nct":"NCT04343729","title":"Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-08-31","completion_date":"2020-08-31","first_posted_date":"2020-04-12"},{"id":227,"nct":"NCT04322786","title":"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?","status":"Active, not recruiting","result":"No Results Available","phases":"","start_date":"1997-12-31","primary_completion_date":"2016-05-30","completion_date":"2020-03-30","first_posted_date":"2020-03-25"},{"id":226,"nct":"NCT04345419","title":"A Real-life Experience on Treatment of Patients With COVID 19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-14","primary_completion_date":"2029-11-30","completion_date":"2029-11-30","first_posted_date":"2020-04-13"},{"id":225,"nct":"NCT04336410","title":"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-04-02","primary_completion_date":"2020-10-31","completion_date":"2020-10-31","first_posted_date":"2020-04-06"},{"id":224,"nct":"NCT04322773","title":"Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-04","primary_completion_date":"2021-05-31","completion_date":"2021-05-31","first_posted_date":"2020-03-25"},{"id":223,"nct":"NCT04306393","title":"Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-20","primary_completion_date":"2021-03-20","completion_date":"2022-03-20","first_posted_date":"2020-03-11"},{"id":222,"nct":"NCT04322344","title":"Escin in Patients With Covid-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-22","primary_completion_date":"2020-06-29","completion_date":"2020-08-29","first_posted_date":"2020-03-25"},{"id":221,"nct":"NCT04338802","title":"Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-01","primary_completion_date":"2020-05-03","completion_date":"2020-07-31","first_posted_date":"2020-04-07"},{"id":220,"nct":"NCT04288713","title":"Eculizumab (Soliris) in Covid-19 Infected Patients","status":"Available","result":"No Results Available","phases":"","start_date":null,"primary_completion_date":null,"completion_date":null,"first_posted_date":"2020-02-27"},{"id":219,"nct":"NCT04257656","title":"Severe 2019-nCoV Remdesivir RCT","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-02-05","primary_completion_date":"2020-04-02","completion_date":"2020-04-30","first_posted_date":"2020-02-05"},{"id":218,"nct":"NCT04290858","title":"Nitric Oxide Gas Inhalation Therapy for Mild\/Moderate COVID19 Infection","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-29","primary_completion_date":"2021-02-28","completion_date":"2022-01-31","first_posted_date":"2020-03-01"},{"id":217,"nct":"NCT04344288","title":"Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-10-31","completion_date":"2020-10-31","first_posted_date":"2020-04-13"},{"id":216,"nct":"NCT04345406","title":"Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-14","primary_completion_date":"2029-11-30","completion_date":"2029-11-30","first_posted_date":"2020-04-13"},{"id":215,"nct":"NCT04326426","title":"ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-07-31","completion_date":"2020-08-30","first_posted_date":"2020-03-29"},{"id":214,"nct":"NCT04336748","title":"HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2020-07-31","first_posted_date":"2020-04-06"},{"id":213,"nct":"NCT04260594","title":"Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-02-06","primary_completion_date":"2020-06-30","completion_date":"2020-12-29","first_posted_date":"2020-02-06"},{"id":212,"nct":"NCT04321278","title":"Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-27","primary_completion_date":"2020-08-29","completion_date":"2020-08-29","first_posted_date":"2020-03-24"},{"id":211,"nct":"NCT04345289","title":"Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-19","primary_completion_date":"2021-06-14","completion_date":"2021-06-14","first_posted_date":"2020-04-13"},{"id":210,"nct":"NCT04344041","title":"COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-04-13"},{"id":209,"nct":"NCT04324073","title":"Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-26","primary_completion_date":"2021-03-26","completion_date":"2021-12-30","first_posted_date":"2020-03-26"},{"id":208,"nct":"NCT04341610","title":"ASC Therapy for Patients With Severe Respiratory COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-04-19","primary_completion_date":"2021-01-29","completion_date":"2021-04-29","first_posted_date":"2020-04-09"},{"id":207,"nct":"NCT04322396","title":"Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2020-10-30","completion_date":"2021-03-30","first_posted_date":"2020-03-25"},{"id":206,"nct":"NCT04326036","title":"Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection","status":"Enrolling by invitation","result":"No Results Available","phases":"Early Phase 1","start_date":"2020-03-24","primary_completion_date":"2021-10-31","completion_date":"2021-12-30","first_posted_date":"2020-03-29"},{"id":205,"nct":"NCT04337918","title":"Nitric Oxide Releasing Solutions to Prevent and Treat Mild\/Moderate COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2020-07-30","completion_date":"2020-09-29","first_posted_date":"2020-04-07"},{"id":204,"nct":"NCT04322123","title":"Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-08-29","completion_date":"2020-08-29","first_posted_date":"2020-03-25"},{"id":203,"nct":"NCT04326725","title":"Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia","status":"Recruiting","result":"No Results Available","phases":"","start_date":"2020-03-19","primary_completion_date":"2020-06-30","completion_date":"2020-08-31","first_posted_date":"2020-03-29"},{"id":202,"nct":"NCT04338906","title":"Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-05-31","primary_completion_date":"2021-05-31","completion_date":"2021-12-30","first_posted_date":"2020-04-07"},{"id":201,"nct":"NCT04325893","title":"Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-08-31","completion_date":"2020-08-31","first_posted_date":"2020-03-29"},{"id":200,"nct":"NCT04327388","title":"Sarilumab COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-28","primary_completion_date":"2020-06-30","completion_date":"2021-05-31","first_posted_date":"2020-03-30"},{"id":199,"nct":"NCT03808922","title":"Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2019-05-22","primary_completion_date":"2021-04-29","completion_date":"2021-12-27","first_posted_date":"2019-01-17"},{"id":198,"nct":"NCT04315480","title":"Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-11","primary_completion_date":"2020-04-08","completion_date":"2020-04-30","first_posted_date":"2020-03-18"},{"id":197,"nct":"NCT04341493","title":"Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-05","primary_completion_date":"2020-08-29","completion_date":"2020-12-29","first_posted_date":"2020-04-09"},{"id":196,"nct":"NCT04290871","title":"Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-22","primary_completion_date":"2021-02-28","completion_date":"2022-02-28","first_posted_date":"2020-03-01"},{"id":195,"nct":"NCT04320238","title":"Experimental Trial of rhIFN\u03b1 Nasal Drops to Prevent 2019-nCOV in Medical Staff","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-01-20","primary_completion_date":"2020-04-30","completion_date":"2020-05-31","first_posted_date":"2020-03-23"},{"id":194,"nct":"NCT04333654","title":"Hydroxychloroquine in Outpatient Adults With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-03-30","primary_completion_date":"2020-04-30","completion_date":"2020-04-30","first_posted_date":"2020-04-02"},{"id":193,"nct":"NCT04293887","title":"Efficacy and Safety of IFN-\u03b12\u03b2 in the Treatment of Novel Coronavirus Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Early Phase 1","start_date":"2020-02-29","primary_completion_date":"2020-05-29","completion_date":"2020-06-29","first_posted_date":"2020-03-02"},{"id":192,"nct":"NCT04312243","title":"NO Prevention of COVID-19 for Healthcare Providers","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-01","primary_completion_date":"2021-03-19","completion_date":"2022-03-19","first_posted_date":"2020-03-17"},{"id":191,"nct":"NCT04264858","title":"Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-16","primary_completion_date":"2020-04-29","completion_date":"2020-05-30","first_posted_date":"2020-02-10"},{"id":190,"nct":"NCT04322565","title":"Colchicine Efficacy in COVID-19 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-05-29","completion_date":"2020-06-29","first_posted_date":"2020-03-25"},{"id":189,"nct":"NCT04334629","title":"LIBA Trial in COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-05","primary_completion_date":"2020-08-04","completion_date":"2020-11-04","first_posted_date":"2020-04-05"},{"id":188,"nct":"NCT04323592","title":"Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-22","primary_completion_date":"2020-05-19","completion_date":"2020-05-29","first_posted_date":"2020-03-25"},{"id":187,"nct":"NCT04321174","title":"COVID-19 Ring-based Prevention Trial With Lopinavir\/Ritonavir","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-29","primary_completion_date":"2021-03-30","completion_date":"2022-03-30","first_posted_date":"2020-03-24"},{"id":186,"nct":"NCT04345614","title":"A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-07","primary_completion_date":"2020-06-30","completion_date":"2020-08-31","first_posted_date":"2020-04-13"},{"id":185,"nct":"NCT04279197","title":"Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-14","primary_completion_date":"2022-11-30","completion_date":"2022-11-30","first_posted_date":"2020-02-20"},{"id":184,"nct":"NCT04280705","title":"Adaptive COVID-19 Treatment Trial (ACTT)","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-02-20","primary_completion_date":"2020-05-20","completion_date":"2020-05-20","first_posted_date":"2020-02-20"},{"id":183,"nct":"NCT04327401","title":"COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-08-29","completion_date":"2020-08-29","first_posted_date":"2020-03-30"},{"id":182,"nct":"NCT04342156","title":"Safety And Efficacy Of Hydroxychloroquine As COVID-19 Prophylaxis For At-Risk Population (SHARP): A Cluster Randomized Controlled Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-07-31","completion_date":"2020-09-30","first_posted_date":"2020-04-09"},{"id":181,"nct":"NCT04342650","title":"Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-07","primary_completion_date":"2020-08-31","completion_date":"2020-08-31","first_posted_date":"2020-04-12"},{"id":180,"nct":"NCT04320277","title":"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-15","primary_completion_date":"2020-04-29","completion_date":"2020-04-29","first_posted_date":"2020-03-23"},{"id":179,"nct":"NCT04324463","title":"Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-09-29","completion_date":"2020-12-30","first_posted_date":"2020-03-26"},{"id":178,"nct":"NCT04305457","title":"Nitric Oxide Gas Inhalation Therapy for Mild\/Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-20","primary_completion_date":"2021-03-31","completion_date":"2022-03-31","first_posted_date":"2020-03-11"},{"id":177,"nct":"NCT04327505","title":"Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-24","primary_completion_date":"2021-10-30","completion_date":"2022-12-30","first_posted_date":"2020-03-30"},{"id":176,"nct":"NCT02735707","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2016-04-10","primary_completion_date":"2021-11-30","completion_date":"2022-05-31","first_posted_date":"2016-04-12"},{"id":175,"nct":"NCT04340349","title":"Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals","status":"Not yet recruiting","result":"No Results Available","phases":"Early Phase 1","start_date":"2020-04-09","primary_completion_date":"2020-06-08","completion_date":"2020-07-09","first_posted_date":"2020-04-08"},{"id":174,"nct":"NCT04252274","title":"Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-01-29","primary_completion_date":"2020-08-30","completion_date":"2020-12-30","first_posted_date":"2020-02-04"},{"id":173,"nct":"NCT04341480","title":"The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"","start_date":"2020-04-09","primary_completion_date":"2020-07-09","completion_date":"2020-07-09","first_posted_date":"2020-04-09"},{"id":172,"nct":"NCT04263402","title":"The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-01-31","primary_completion_date":"2020-05-31","completion_date":"2020-06-30","first_posted_date":"2020-02-09"},{"id":171,"nct":"NCT04321616","title":"The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-27","primary_completion_date":"2020-07-31","completion_date":"2020-10-31","first_posted_date":"2020-03-24"},{"id":170,"nct":"NCT04311697","title":"Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-07-31","completion_date":"2020-08-31","first_posted_date":"2020-03-16"},{"id":169,"nct":"NCT04329195","title":"ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-08","primary_completion_date":"2020-05-08","completion_date":"2020-05-08","first_posted_date":"2020-03-31"},{"id":168,"nct":"NCT04332042","title":"TOFAcitinib in SARS-CoV2 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-09","primary_completion_date":"2020-06-19","completion_date":"2020-07-09","first_posted_date":"2020-04-01"},{"id":167,"nct":"NCT04342169","title":"University of Utah COVID-19 Hydrochloroquine Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-13","primary_completion_date":"2022-03-31","completion_date":"2023-03-31","first_posted_date":"2020-04-09"},{"id":166,"nct":"NCT04261270","title":"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-01-31","primary_completion_date":"2020-04-30","completion_date":"2020-06-30","first_posted_date":"2020-02-06"},{"id":165,"nct":"NCT04341935","title":"Effects of DPP4 Inhibition on COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-29","primary_completion_date":"2020-06-29","completion_date":"2020-09-29","first_posted_date":"2020-04-09"},{"id":164,"nct":"NCT04275414","title":"Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-02-14","primary_completion_date":"2020-03-31","completion_date":"2020-04-30","first_posted_date":"2020-02-18"},{"id":163,"nct":"NCT04254874","title":"A Prospective\/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-01-31","primary_completion_date":"2020-05-31","completion_date":"2020-06-30","first_posted_date":"2020-02-04"},{"id":162,"nct":"NCT04255017","title":"A Prospective\/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-01-31","primary_completion_date":"2020-05-31","completion_date":"2020-06-30","first_posted_date":"2020-02-04"},{"id":161,"nct":"NCT04261426","title":"The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-02-09","primary_completion_date":"2020-04-29","completion_date":"2020-06-29","first_posted_date":"2020-02-06"},{"id":160,"nct":"NCT04311177","title":"Losartan for Patients With COVID-19 Not Requiring Hospitalization","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-08","primary_completion_date":"2021-03-31","completion_date":"2021-03-31","first_posted_date":"2020-03-16"},{"id":159,"nct":"NCT04315948","title":"Trial of Treatments for COVID-19 in Hospitalized Adults","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-21","primary_completion_date":"2023-02-28","completion_date":"2023-02-28","first_posted_date":"2020-03-19"},{"id":158,"nct":"NCT04312009","title":"Losartan for Patients With COVID-19 Requiring Hospitalization","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-01","primary_completion_date":"2021-03-31","completion_date":"2021-03-31","first_posted_date":"2020-03-16"},{"id":157,"nct":"NCT04252664","title":"Mild\/Moderate 2019-nCoV Remdesivir RCT","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-02-11","primary_completion_date":"2020-04-09","completion_date":"2020-04-26","first_posted_date":"2020-02-04"},{"id":156,"nct":"NCT04306705","title":"Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19","status":"Recruiting","result":"No Results Available","phases":"","start_date":"2020-02-19","primary_completion_date":"2020-05-29","completion_date":"2020-06-19","first_posted_date":"2020-03-12"},{"id":155,"nct":"NCT04332835","title":"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-08-30","completion_date":"2020-12-30","first_posted_date":"2020-04-02"},{"id":154,"nct":"NCT04334928","title":"Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-06-29","completion_date":"2020-07-30","first_posted_date":"2020-04-05"},{"id":153,"nct":"NCT04330495","title":"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and \/ or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-05","primary_completion_date":"2020-11-05","completion_date":"2020-11-05","first_posted_date":"2020-03-31"},{"id":152,"nct":"NCT04268537","title":"Immunoregulatory Therapy for 2019-nCoV","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-09","primary_completion_date":"2020-04-29","completion_date":"2020-10-30","first_posted_date":"2020-02-12"},{"id":151,"nct":"NCT04332666","title":"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-30","primary_completion_date":"2020-05-29","completion_date":"2020-06-14","first_posted_date":"2020-04-02"},{"id":150,"nct":"NCT04332380","title":"Convalescent Plasma for Patients With COVID-19: A Pilot Study","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-08-30","completion_date":"2020-12-30","first_posted_date":"2020-04-01"},{"id":149,"nct":"NCT04321096","title":"The Impact of Camostat Mesilate on COVID-19 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-03-30","primary_completion_date":"2020-12-30","completion_date":"2021-04-30","first_posted_date":"2020-03-24"},{"id":148,"nct":"NCT04344379","title":"Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-13","primary_completion_date":"2020-07-30","completion_date":"2020-08-30","first_posted_date":"2020-04-13"},{"id":147,"nct":"NCT04285190","title":"The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-02-25","primary_completion_date":"2020-06-14","completion_date":"2020-09-14","first_posted_date":"2020-02-25"},{"id":146,"nct":"NCT04343651","title":"Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-12-03","completion_date":"2021-04-03","first_posted_date":"2020-04-12"},{"id":145,"nct":"NCT04332991","title":"Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-01","primary_completion_date":"2021-03-31","completion_date":"2021-06-30","first_posted_date":"2020-04-02"},{"id":144,"nct":"NCT04298060","title":"DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-02-28","completion_date":"2022-08-31","first_posted_date":"2020-03-05"},{"id":143,"nct":"NCT04334967","title":"Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care","status":"Enrolling by invitation","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-29","primary_completion_date":"2021-09-29","completion_date":"2023-09-29","first_posted_date":"2020-04-05"},{"id":142,"nct":"NCT04323761","title":"Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)","status":"Available","result":"No Results Available","phases":"","start_date":null,"primary_completion_date":null,"completion_date":null,"first_posted_date":"2020-03-26"},{"id":141,"nct":"NCT04344600","title":"Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-11-30","completion_date":"2021-05-31","first_posted_date":"2020-04-13"},{"id":140,"nct":"NCT04310865","title":"Yinhu Qingwen Granula for the Treatment of Severe CoVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-19","primary_completion_date":"2021-03-29","completion_date":"2021-06-29","first_posted_date":"2020-03-16"},{"id":139,"nct":"NCT04273763","title":"Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment\/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)","status":"Enrolling by invitation","result":"No Results Available","phases":"Not Applicable","start_date":"2020-02-15","primary_completion_date":"2020-04-14","completion_date":"2020-04-29","first_posted_date":"2020-02-17"},{"id":138,"nct":"NCT04335032","title":"EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-12","primary_completion_date":"2020-07-12","completion_date":"2020-07-30","first_posted_date":"2020-04-05"},{"id":137,"nct":"NCT04328012","title":"COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-05","primary_completion_date":"2020-12-31","completion_date":"2021-03-31","first_posted_date":"2020-03-30"},{"id":136,"nct":"NCT04303507","title":"Chloroquine\/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-31","primary_completion_date":"2021-03-31","completion_date":"2021-03-31","first_posted_date":"2020-03-10"},{"id":135,"nct":"NCT04278963","title":"Yinhu Qingwen Decoction for the Treatment of Mild \/ Common CoVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-02-26","primary_completion_date":"2020-12-31","completion_date":"2020-12-31","first_posted_date":"2020-02-19"},{"id":134,"nct":"NCT04335552","title":"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-07-31","completion_date":"2020-07-31","first_posted_date":"2020-04-05"},{"id":133,"nct":"NCT04335786","title":"Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2021-07-31","first_posted_date":"2020-04-05"},{"id":132,"nct":"NCT04295551","title":"Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-13","primary_completion_date":"2020-07-13","completion_date":"2021-04-13","first_posted_date":"2020-03-03"},{"id":131,"nct":"NCT04310228","title":"Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-07","primary_completion_date":"2020-04-30","completion_date":"2020-04-30","first_posted_date":"2020-03-16"},{"id":130,"nct":"NCT04328480","title":"The ECLA PHRI COLCOVID Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-02-29","primary_completion_date":"2020-05-29","completion_date":"2020-06-29","first_posted_date":"2020-03-30"},{"id":129,"nct":"NCT04333589","title":"Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-09-14","first_posted_date":"2020-04-02"},{"id":128,"nct":"NCT04334148","title":"Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-04-05"},{"id":127,"nct":"NCT04334265","title":"Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-11-30","first_posted_date":"2020-04-05"},{"id":126,"nct":"NCT04339712","title":"Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2022-03-31","completion_date":"2022-03-31","first_posted_date":"2020-04-08"},{"id":125,"nct":"NCT04331054","title":"Protective Role of Inhaled Steroids for Covid-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-04-01"},{"id":124,"nct":"NCT04338698","title":"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-06","primary_completion_date":"2020-08-31","completion_date":"2020-11-29","first_posted_date":"2020-04-07"},{"id":123,"nct":"NCT04344184","title":"Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-21","primary_completion_date":"2021-03-31","completion_date":"2021-04-30","first_posted_date":"2020-04-13"},{"id":122,"nct":"NCT04326790","title":"The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2020-08-30","completion_date":"2020-09-29","first_posted_date":"2020-03-29"},{"id":121,"nct":"NCT04327206","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-29","primary_completion_date":"2020-10-29","completion_date":"2022-03-29","first_posted_date":"2020-03-30"},{"id":120,"nct":"NCT04333732","title":"CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-01-31","completion_date":"2021-01-31","first_posted_date":"2020-04-02"},{"id":119,"nct":"NCT04330300","title":"Coronavirus (COVID-19) ACEi\/ARB Investigation","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-29","primary_completion_date":"2021-01-30","completion_date":"2021-02-28","first_posted_date":"2020-03-31"},{"id":118,"nct":"NCT04341441","title":"Will Hydroxychloroquine Impede or Prevent COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-06","primary_completion_date":"2020-06-29","completion_date":"2021-04-29","first_posted_date":"2020-04-09"},{"id":117,"nct":"NCT04334460","title":"Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-30","primary_completion_date":"2020-07-31","completion_date":"2020-08-31","first_posted_date":"2020-04-05"},{"id":116,"nct":"NCT04341207","title":"Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-02","primary_completion_date":"2022-03-31","completion_date":"2022-03-31","first_posted_date":"2020-04-09"},{"id":115,"nct":"NCT04345653","title":"Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-13","primary_completion_date":"2021-04-07","completion_date":"2022-04-07","first_posted_date":"2020-04-13"},{"id":114,"nct":"NCT04328961","title":"Hydroxychloroquine for COVID-19 PEP","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-02-29","primary_completion_date":"2020-09-29","completion_date":"2020-10-30","first_posted_date":"2020-03-31"},{"id":113,"nct":"NCT04343963","title":"Pyridostigmine in Severe SARS-CoV-2 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-03","primary_completion_date":"2020-09-29","completion_date":"2021-04-29","first_posted_date":"2020-04-13"},{"id":112,"nct":"NCT04335071","title":"Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-09-30","completion_date":"2020-09-30","first_posted_date":"2020-04-05"},{"id":111,"nct":"NCT04343092","title":"Ivermectin Adjuvant to Hydroxychloroquin in COVID19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1","start_date":"2020-04-07","primary_completion_date":"2020-07-31","completion_date":"2020-07-31","first_posted_date":"2020-04-12"},{"id":110,"nct":"NCT04338126","title":"Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-14","primary_completion_date":"2020-10-14","completion_date":"2020-12-14","first_posted_date":"2020-04-07"},{"id":109,"nct":"NCT04338958","title":"Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-30","primary_completion_date":"2021-01-30","completion_date":"2021-08-30","first_posted_date":"2020-04-07"},{"id":108,"nct":"NCT04343144","title":"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo\u00ae) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-14","primary_completion_date":"2020-07-30","completion_date":"2020-09-29","first_posted_date":"2020-04-12"},{"id":107,"nct":"NCT04341688","title":"A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load in COVID-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-06-30","primary_completion_date":"2020-12-30","completion_date":"2021-03-30","first_posted_date":"2020-04-09"},{"id":106,"nct":"NCT04330144","title":"Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2021-03-29","completion_date":"2022-03-29","first_posted_date":"2020-03-31"},{"id":105,"nct":"NCT04261517","title":"Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-02-05","primary_completion_date":"2020-02-24","completion_date":"2020-02-24","first_posted_date":"2020-02-06"},{"id":104,"nct":"NCT04344951","title":"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2021-03-31","completion_date":"2021-04-29","first_posted_date":"2020-04-13"},{"id":103,"nct":"NCT04341870","title":"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-10","primary_completion_date":"2020-04-30","completion_date":"2020-06-30","first_posted_date":"2020-04-09"},{"id":102,"nct":"NCT04333914","title":"Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-07-31","first_posted_date":"2020-04-02"},{"id":101,"nct":"NCT04343001","title":"Coronavirus Response - Active Support for Hospitalised Covid-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2021-03-31","completion_date":"2021-07-31","first_posted_date":"2020-04-12"},{"id":100,"nct":"NCT04342663","title":"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-09","primary_completion_date":"2020-05-31","completion_date":"2020-06-30","first_posted_date":"2020-04-12"},{"id":99,"nct":"NCT04344782","title":"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin\u00ae\/Zeribev\u00ae) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-14","primary_completion_date":"2020-09-29","completion_date":"2020-11-29","first_posted_date":"2020-04-13"},{"id":98,"nct":"NCT04344756","title":"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-19","primary_completion_date":"2020-07-30","completion_date":"2020-09-29","first_posted_date":"2020-04-13"},{"id":97,"nct":"NCT04328272","title":"Effectiveness of Hydroxychloroquine in Covid-19 Patients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-27","primary_completion_date":"2020-05-27","completion_date":"2020-06-27","first_posted_date":"2020-03-30"},{"id":96,"nct":"NCT04341038","title":"Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-06-30","first_posted_date":"2020-04-09"},{"id":95,"nct":"NCT04318015","title":"Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-12-30","completion_date":"2021-03-30","first_posted_date":"2020-03-22"},{"id":94,"nct":"NCT04344730","title":"Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-04-09","primary_completion_date":"2020-12-30","completion_date":"2020-12-30","first_posted_date":"2020-04-13"},{"id":93,"nct":"NCT04318444","title":"Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-02-29","primary_completion_date":"2021-02-28","completion_date":"2022-02-28","first_posted_date":"2020-03-23"},{"id":92,"nct":"NCT04331665","title":"Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-04-19","primary_completion_date":"2020-10-29","completion_date":"2021-01-30","first_posted_date":"2020-04-01"},{"id":91,"nct":"NCT04339426","title":"Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-31","primary_completion_date":"2020-09-30","completion_date":"2021-03-31","first_posted_date":"2020-04-08"},{"id":90,"nct":"NCT04343976","title":"Pegylated Interferon Lambda Treatment for COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-21","primary_completion_date":"2021-07-29","completion_date":"2021-07-29","first_posted_date":"2020-04-13"},{"id":89,"nct":"NCT04273321","title":"Efficacy and Safety of Corticosteroids in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-02-13","primary_completion_date":"2020-04-30","completion_date":"2020-05-29","first_posted_date":"2020-02-17"},{"id":88,"nct":"NCT04335305","title":"Checkpoint Blockade in COVID-19 Pandemic","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-29","primary_completion_date":"2020-05-14","completion_date":"2020-05-14","first_posted_date":"2020-04-05"},{"id":87,"nct":"NCT04338828","title":"Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-03-31","completion_date":"2022-03-31","first_posted_date":"2020-04-07"},{"id":86,"nct":"NCT04333472","title":"Piclidenoson for Treatment of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2020-06-05","completion_date":"2020-07-05","first_posted_date":"2020-04-02"},{"id":85,"nct":"NCT04339816","title":"Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-19","primary_completion_date":"2021-12-30","completion_date":"2022-06-29","first_posted_date":"2020-04-08"},{"id":84,"nct":"NCT04291729","title":"Evaluation of Ganovo \uff08Danoprevir \uff09 Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2020-02-16","primary_completion_date":"2020-03-18","completion_date":"2020-03-18","first_posted_date":"2020-03-01"},{"id":83,"nct":"NCT04345276","title":"Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-17","primary_completion_date":"2020-04-29","completion_date":"2020-05-30","first_posted_date":"2020-04-13"},{"id":82,"nct":"NCT04303299","title":"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-14","primary_completion_date":"2020-10-30","completion_date":"2020-11-29","first_posted_date":"2020-03-10"},{"id":81,"nct":"NCT04286503","title":"The Clinical Study of Carrimycin on Treatment Patients With COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-02-22","primary_completion_date":"2021-02-27","completion_date":"2021-02-27","first_posted_date":"2020-02-26"},{"id":80,"nct":"NCT04342897","title":"A Study of LY3127804 in Participants With COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-17","primary_completion_date":"2020-07-09","completion_date":"2020-07-09","first_posted_date":"2020-04-12"},{"id":79,"nct":"NCT04317040","title":"CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-07","primary_completion_date":"2021-04-30","completion_date":"2022-04-30","first_posted_date":"2020-03-19"},{"id":78,"nct":"NCT04336332","title":"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-04-29","completion_date":"2021-04-29","first_posted_date":"2020-04-06"},{"id":77,"nct":"NCT04328493","title":"The Vietnam Chloroquine Treatment on COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-03-31","completion_date":"2022-03-31","first_posted_date":"2020-03-30"},{"id":76,"nct":"NCT04341116","title":"Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-08-31","completion_date":"2020-08-31","first_posted_date":"2020-04-09"},{"id":75,"nct":"NCT04334044","title":"Treatment of SARS Caused by COVID-19 With Ruxolitinib","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-05-31","first_posted_date":"2020-04-02"},{"id":74,"nct":"NCT04328441","title":"Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-24","primary_completion_date":"2021-03-30","completion_date":"2021-05-29","first_posted_date":"2020-03-30"},{"id":73,"nct":"NCT04273646","title":"Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-04-19","primary_completion_date":"2020-06-29","completion_date":"2022-02-14","first_posted_date":"2020-02-17"},{"id":72,"nct":"NCT04332107","title":"Azithromycin for COVID-19 Treatment in Outpatients Nationwide","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-07-29","completion_date":"2021-07-29","first_posted_date":"2020-04-01"},{"id":71,"nct":"NCT04337359","title":"Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe\/Very Severe COVID-19 Illness","status":"Available","result":"No Results Available","phases":"","start_date":null,"primary_completion_date":null,"completion_date":null,"first_posted_date":"2020-04-06"},{"id":70,"nct":"NCT04343248","title":"Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-05-11","primary_completion_date":"2021-06-29","completion_date":"2021-06-29","first_posted_date":"2020-04-12"},{"id":69,"nct":"NCT04335201","title":"Defibrotide in COVID-19 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-05","primary_completion_date":"2020-09-29","completion_date":"2020-12-30","first_posted_date":"2020-04-05"},{"id":68,"nct":"NCT04315896","title":"Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-22","primary_completion_date":"2020-10-30","completion_date":"2021-03-21","first_posted_date":"2020-03-19"},{"id":67,"nct":"NCT04280588","title":"Fingolimod in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-21","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-02-20"},{"id":66,"nct":"NCT04325061","title":"Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-02","primary_completion_date":"2020-10-29","completion_date":"2020-10-29","first_posted_date":"2020-03-26"},{"id":65,"nct":"NCT04331600","title":"ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 4","start_date":"2020-04-05","primary_completion_date":"2020-09-29","completion_date":"2020-12-30","first_posted_date":"2020-04-01"},{"id":64,"nct":"NCT04343742","title":"Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19","status":"Recruiting","result":"No Results Available","phases":"","start_date":"2020-03-31","primary_completion_date":"2020-04-06","completion_date":"2020-05-31","first_posted_date":"2020-04-12"},{"id":63,"nct":"NCT04344457","title":"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-04-15","primary_completion_date":"2020-06-19","completion_date":"2020-09-29","first_posted_date":"2020-04-13"},{"id":62,"nct":"NCT04338074","title":"TXA and Corona Virus 2019 (COVID19) in Outpatients","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-14","primary_completion_date":"2020-10-14","completion_date":"2020-10-29","first_posted_date":"2020-04-07"},{"id":61,"nct":"NCT04342221","title":"Hydroxychloroquine for COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-28","primary_completion_date":"2021-02-25","completion_date":"2021-02-25","first_posted_date":"2020-04-09"},{"id":60,"nct":"NCT04273581","title":"The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-17","primary_completion_date":"2020-04-29","completion_date":"2020-05-29","first_posted_date":"2020-02-17"},{"id":59,"nct":"NCT04273529","title":"The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-02-19","primary_completion_date":"2020-05-29","completion_date":"2020-06-29","first_posted_date":"2020-02-17"},{"id":58,"nct":"NCT04320615","title":"A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-02","primary_completion_date":"2021-08-30","completion_date":"2021-09-29","first_posted_date":"2020-03-24"},{"id":57,"nct":"NCT04308317","title":"Tetrandrine Tablets Used in the Treatment of COVID-19","status":"Enrolling by invitation","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-04","primary_completion_date":"2021-02-28","completion_date":"2021-04-30","first_posted_date":"2020-03-15"},{"id":56,"nct":"NCT04305106","title":"Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-16","primary_completion_date":"2020-06-29","completion_date":"2020-07-30","first_posted_date":"2020-03-11"},{"id":55,"nct":"NCT04331470","title":"Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-04-03","primary_completion_date":"2020-04-19","completion_date":"2020-05-19","first_posted_date":"2020-04-01"},{"id":54,"nct":"NCT04329650","title":"Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-05-19","completion_date":"2020-05-19","first_posted_date":"2020-03-31"},{"id":53,"nct":"NCT04345523","title":"Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-02","primary_completion_date":"2021-02-04","completion_date":"2021-04-04","first_posted_date":"2020-04-13"},{"id":52,"nct":"NCT04292730","title":"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u2122) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-03-14","primary_completion_date":"2020-04-28","completion_date":"2020-06-25","first_posted_date":"2020-03-02"},{"id":51,"nct":"NCT04329572","title":"Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19","status":"Suspended","result":"No Results Available","phases":"Early Phase 1","start_date":"2020-04-22","primary_completion_date":"2020-05-30","completion_date":"2020-06-29","first_posted_date":"2020-03-31"},{"id":50,"nct":"NCT04343989","title":"A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-30","primary_completion_date":"2021-02-02","completion_date":"2021-03-11","first_posted_date":"2020-04-13"},{"id":49,"nct":"NCT04312997","title":"The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-15","primary_completion_date":"2021-07-01","completion_date":"2021-07-01","first_posted_date":"2020-03-17"},{"id":48,"nct":"NCT04292899","title":"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u2122) in Participants With Severe Coronavirus Disease (COVID-19)","status":"Completed","result":"Has Results","phases":"Phase 3","start_date":"2020-03-05","primary_completion_date":"2020-04-08","completion_date":"2020-06-29","first_posted_date":"2020-03-02"},{"id":47,"nct":"NCT04332094","title":"Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-01","primary_completion_date":"2021-05-31","completion_date":"2021-06-30","first_posted_date":"2020-04-01"},{"id":46,"nct":"NCT04313023","title":"The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-06-08","primary_completion_date":"2021-07-30","completion_date":"2021-07-30","first_posted_date":"2020-03-17"},{"id":45,"nct":"NCT04337216","title":"Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-04-06"},{"id":44,"nct":"NCT04331834","title":"Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-02","primary_completion_date":"2020-06-24","completion_date":"2020-12-30","first_posted_date":"2020-04-01"},{"id":43,"nct":"NCT04323631","title":"Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death","status":"Withdrawn","result":"No Results Available","phases":"Early Phase 1","start_date":"2020-04-29","primary_completion_date":"2020-04-29","completion_date":"2020-04-29","first_posted_date":"2020-03-25"},{"id":42,"nct":"NCT04345692","title":"A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-25","primary_completion_date":"2020-08-30","completion_date":"2020-08-30","first_posted_date":"2020-04-13"},{"id":41,"nct":"NCT04307693","title":"Comparison of Lopinavir\/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-10","primary_completion_date":"2020-04-29","completion_date":"2020-04-29","first_posted_date":"2020-03-12"},{"id":40,"nct":"NCT04344236","title":"Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-08","primary_completion_date":"2020-04-30","completion_date":"2020-05-08","first_posted_date":"2020-04-13"},{"id":39,"nct":"NCT04335084","title":"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-03-31","completion_date":"2021-06-30","first_posted_date":"2020-04-05"},{"id":38,"nct":"NCT04344444","title":"Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-12","primary_completion_date":"2021-04-09","completion_date":"2021-12-09","first_posted_date":"2020-04-13"},{"id":37,"nct":"NCT04333225","title":"Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-04-02","primary_completion_date":"2020-06-29","completion_date":"2020-06-29","first_posted_date":"2020-04-02"},{"id":36,"nct":"NCT04331795","title":"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-03","primary_completion_date":"2020-06-04","completion_date":"2020-06-04","first_posted_date":"2020-04-01"},{"id":35,"nct":"NCT04335136","title":"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-04-29","primary_completion_date":"2020-12-25","completion_date":"2020-12-25","first_posted_date":"2020-04-05"},{"id":34,"nct":"NCT04334382","title":"Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-01","primary_completion_date":"2020-12-30","completion_date":"2021-12-30","first_posted_date":"2020-04-05"},{"id":33,"nct":"NCT04304053","title":"Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-17","primary_completion_date":"2020-06-14","completion_date":"2020-06-14","first_posted_date":"2020-03-10"},{"id":32,"nct":"NCT04333628","title":"Chloroquine for Mild Symptomatic and Asymptomatic COVID-19","status":"Terminated","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-05-31","primary_completion_date":"2020-08-31","completion_date":"2020-08-31","first_posted_date":"2020-04-02"},{"id":31,"nct":"NCT04330690","title":"Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-17","primary_completion_date":"2022-03-17","completion_date":"2022-05-17","first_posted_date":"2020-03-31"},{"id":30,"nct":"NCT04329923","title":"The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)","status":"Terminated","result":"Has Results","phases":"Phase 2","start_date":"2020-04-08","primary_completion_date":"2020-11-10","completion_date":"2020-11-12","first_posted_date":"2020-03-31"},{"id":29,"nct":"NCT04341675","title":"Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-23","primary_completion_date":"2020-06-30","completion_date":"2020-08-31","first_posted_date":"2020-04-09"},{"id":28,"nct":"NCT04334512","title":"A Study of Quintuple Therapy to Treat COVID-19 Infection","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-03-31","completion_date":"2021-06-30","first_posted_date":"2020-04-05"},{"id":27,"nct":"NCT04340544","title":"Hydroxychloroquine for the Treatment of Mild COVID-19 Disease","status":"Terminated","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-21","primary_completion_date":"2020-10-11","completion_date":"2020-10-11","first_posted_date":"2020-04-08"},{"id":26,"nct":"NCT04326920","title":"Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)","status":"Completed","result":"No Results Available","phases":"Phase 4","start_date":"2020-03-23","primary_completion_date":"2020-09-27","completion_date":"2021-02-25","first_posted_date":"2020-03-29"},{"id":25,"nct":"NCT04304313","title":"A Pilot Study of Sildenafil in COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-02-08","primary_completion_date":"2020-02-29","completion_date":"2020-11-08","first_posted_date":"2020-03-10"},{"id":24,"nct":"NCT04343677","title":"Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-05-31","completion_date":"2020-07-31","first_posted_date":"2020-04-12"},{"id":23,"nct":"NCT04330638","title":"Treatment of COVID-19 Patients With Anti-interleukin Drugs","status":"Completed","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-02","primary_completion_date":"2020-12-17","completion_date":"2021-04-11","first_posted_date":"2020-03-31"},{"id":22,"nct":"NCT04315298","title":"Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19","status":"Completed","result":"Has Results","phases":"Phase 2, Phase 3","start_date":"2020-03-17","primary_completion_date":"2020-07-23","completion_date":"2020-09-01","first_posted_date":"2020-03-18"},{"id":21,"nct":"NCT04331899","title":"Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19","status":"Completed","result":"Has Results","phases":"Phase 2","start_date":"2020-04-24","primary_completion_date":"2020-08-13","completion_date":"2021-05-05","first_posted_date":"2020-04-01"},{"id":20,"nct":"NCT04328285","title":"Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-13","primary_completion_date":"2022-03-29","completion_date":"2022-03-29","first_posted_date":"2020-03-30"},{"id":19,"nct":"NCT04330586","title":"A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-31","primary_completion_date":"2021-03-30","completion_date":"2021-03-30","first_posted_date":"2020-03-31"},{"id":18,"nct":"NCT04317092","title":"Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-18","primary_completion_date":"2021-12-18","completion_date":"2022-12-18","first_posted_date":"2020-03-19"},{"id":17,"nct":"NCT04343768","title":"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial","status":"Completed","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-08","primary_completion_date":"2020-04-26","completion_date":"2020-04-26","first_posted_date":"2020-04-12"},{"id":16,"nct":"NCT04329832","title":"Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-03-29","primary_completion_date":"2020-12-17","completion_date":"2021-12-30","first_posted_date":"2020-03-31"},{"id":15,"nct":"NCT04321993","title":"Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients","status":"Recruiting","result":"No Results Available","phases":"Phase 2","start_date":"2020-04-16","primary_completion_date":"2022-01-31","completion_date":"2022-02-28","first_posted_date":"2020-03-25"},{"id":14,"nct":"NCT04340232","title":"Safety and Efficacy of Baricitinib for COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2021-02-28","primary_completion_date":"2021-07-31","completion_date":"2021-09-30","first_posted_date":"2020-04-08"},{"id":13,"nct":"NCT04287686","title":"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19","status":"Withdrawn","result":"No Results Available","phases":"Not Applicable","start_date":"2020-01-31","primary_completion_date":"2020-03-31","completion_date":"2020-03-31","first_posted_date":"2020-02-26"},{"id":12,"nct":"NCT04306497","title":"TCM Differentiation and Treatment Protocol of COVID-19","status":"Completed","result":"No Results Available","phases":"None","start_date":"2020-01-21","primary_completion_date":"2020-04-29","completion_date":"2020-05-29","first_posted_date":"2020-03-12"},{"id":11,"nct":"NCT04323332","title":"Traditional Chinese Medicine for Severe COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-02-29","primary_completion_date":"2020-02-29","completion_date":"2020-03-31","first_posted_date":"2020-03-25"},{"id":10,"nct":"NCT04325633","title":"Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-23","primary_completion_date":"2020-12-14","completion_date":"2020-12-14","first_posted_date":"2020-03-26"},{"id":9,"nct":"NCT04329611","title":"ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease","status":"Terminated","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-12","primary_completion_date":"2020-07-19","completion_date":"2020-07-19","first_posted_date":"2020-03-31"},{"id":8,"nct":"NCT04333420","title":"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia","status":"Recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-30","primary_completion_date":"2021-09-29","completion_date":"2021-12-30","first_posted_date":"2020-04-02"},{"id":7,"nct":"NCT04335123","title":"Study of Open Label Losartan in COVID-19","status":"Completed","result":"No Results Available","phases":"Phase 1","start_date":"2020-04-03","primary_completion_date":"2020-06-20","completion_date":"2020-08-16","first_posted_date":"2020-04-05"},{"id":6,"nct":"NCT04324489","title":"DAS181 for Severe COVID-19: Compassionate Use","status":"Completed","result":"No Results Available","phases":"Not Applicable","start_date":"2020-03-05","primary_completion_date":"2020-04-15","completion_date":"2020-04-29","first_posted_date":"2020-03-26"},{"id":5,"nct":"NCT04291053","title":"The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 2, Phase 3","start_date":"2020-03-31","primary_completion_date":"2020-07-31","completion_date":"2020-08-31","first_posted_date":"2020-03-01"},{"id":4,"nct":"NCT04333407","title":"Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.","status":"Recruiting","result":"No Results Available","phases":"Not Applicable","start_date":"2020-04-02","primary_completion_date":"2021-03-29","completion_date":"2021-03-29","first_posted_date":"2020-04-02"},{"id":3,"nct":"NCT04345445","title":"Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression","status":"Not yet recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-04-14","primary_completion_date":"2020-10-30","completion_date":"2020-10-30","first_posted_date":"2020-04-13"},{"id":2,"nct":"NCT04336904","title":"Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19","status":"Active, not recruiting","result":"No Results Available","phases":"Phase 3","start_date":"2020-03-24","primary_completion_date":"2020-06-30","completion_date":"2020-06-30","first_posted_date":"2020-04-06"},{"id":1,"nct":"NCT04333550","title":"Application of Desferal to Treat COVID-19","status":"Recruiting","result":"No Results Available","phases":"Phase 1, Phase 2","start_date":"2020-03-31","primary_completion_date":"2020-08-31","completion_date":"2021-02-28","first_posted_date":"2020-04-02"}]}